Other complications of surgical and medical care, not elsewhere classified

ST19_OTHER_COMPLICATIO_SURGI_MEDICAL_CARE_NOT_ELSEW_CLASSIFIED

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T88 Cause of death: ICD-10 — T88 2 out of 7 registries used, show all original rules.	4316
4. Check minimum number of events None	4316
5. Include endpoints None	4316
6. Filter based on genotype QC (FinnGen only)	4167

Control definitions (FinnGen only)

Control exclude: ST19_COMPLICATIO_SURGI_MEDICAL_CARE_NOT_ELSEW_CLASSIFIED

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T8
Name in latin: Aliae complicationes curae chirurgicae et medicinalis non alibi classificatae

NAME	ST19_OTHER_COMPLICATIO_SURGI_MEDICAL_CARE_NOT_ELSEW_CLASSIFIED
CONTROL_EXCLUDE	ST19_COMPLICATIO_SURGI_MEDICAL_CARE_NOT_ELSEW_CLASSIFIED
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T88
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T88
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other complications of surgical and medical care, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4167	2742	1425
Unadjusted period prevalence (%)	0.86	0.97	0.65
Median age at first event (years)	58.15	55.02	64.18

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4316: Matched controls
43160

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

302.8

307.7

283

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

43.0

307.7

232

T88.8

ICD-10 Finland

Other specified complications of surgical and medical care, not elsewhere classified

3099.9

307.7

801

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

98.4

307.7

1388

207

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

757.0

307.7

2250

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

1263.5

307.7

453

T88.9

ICD-10 Finland

Complication of surgical and medical care, unspecified

1949.4

307.7

644

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

32.1

307.7

733

273

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

84.1

307.7

341

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

250.6

307.7

303

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

73.0

307.7

560

XQ820

NOMESCO Finland

Exposure to medicinal substance

49.1

292.9

170

X59

ICD-10 Finland

Exposure to unspecified factor

3.5

267.7

1205

4314

XQ800

NOMESCO Finland

Prick test

4.6

254.2

676

1666

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

243.4

2384

13062

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

97.4

236.6

123

XQ801

NOMESCO Finland

Intracutantest

25.9

232.4

162

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

101.1

228.0

118

N03AX16

ATC

[U] pregabalin

3.0

225.0

1378

5840

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.9

218.4

743

2186

N02AX02

ATC

tramadol; systemic, rectal

2.7

217.7

2201

12043

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

63.3

211.7

117

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

39.3

206.0

126

C01CA24

ATC

epinephrine; parenteral

4.5

204.2

552

1368

H02AB06

ATC

prednisolone; systemic

2.6

202.0

2470

14643

N02AA05

ATC

oxycodone; systemic

3.2

201.5

999

3726

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

10.6

197.1

220

218

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.2

196.1

936

3408

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

75.3

191.6

103

B01AB05

ATC

enoxaparin; parenteral

2.6

185.5

1609

8020

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

12.9

185.5

181

146

J01FF01

ATC

clindamycin; systemic

2.5

167.1

1440

7090

T81.9

ICD-10 Finland

Unspecified complication of procedure

56.5

166.6

T78.4

ICD-10 Finland

Allergy, unspecified

4.7

160.6

393

895

R50.9

ICD-10 Finland

Fever, unspecified

2.9

160.4

889

3491

A03FA01

ATC

metoclopramide; systemic, rectal

2.6

159.1

1240

5799

WX402

NOMESCO Finland

General anaesthesia

2.7

158.8

1156

5228

J01MA12

ATC

levofloxacin; systemic

2.8

156.3

978

4093

N03AX12

ATC

[U] gabapentin; oral

2.8

153.1

939

3884

JN4AD

NOMESCO Finland

Body CT examination

3.5

151.5

597

1913

AA1AD

NOMESCO Finland

CT of head and brain

2.5

149.2

1369

6877

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

148.3

767

2889

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.3

146.2

620

2077

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

144.9

1133

5274

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.0

144.8

746

2801

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

140.7

1853

10810

ZXD05

NOMESCO Finland

Urgent procedure

2.3

139.7

1492

7971

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

135.7

1723

9867

J01MA02

ATC

ciprofloxacin; systemic

2.2

133.0

1827

10777

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

131.4

1434

7693

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

129.9

1276

6540

JN3AD

NOMESCO Finland

Abdominal CT examination

3.0

129.9

642

2346

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

197.5

129.4

134

C03CA01

ATC

furosemide; systemic

2.3

125.0

1329

7027

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.1

123.2

563

1963

X58

ICD-10 Finland

Exposure to other specified factors

2.7

122.2

757

3117

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.1

121.4

352

910

Y88.0

ICD-10 Finland

Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use

45.1

120.0

ZXE20

NOMESCO Finland

More than three and less than five hours

2.8

118.4

680

2689

WZC00

NOMESCO Finland

Treatment plan or consultation

2.1

117.4

1767

10666

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.9

116.8

620

2349

R06.0

ICD-10 Finland

Dyspnoea

2.2

116.0

1308

7049

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

115.3

576

2110

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.1

115.0

534

1876

UJF32

NOMESCO Finland

Coloscopy

2.2

113.5

1253

6684

N02BE01

ATC

paracetamol; systemic, rectal

3.4

112.3

3975

33364

A02BC02

ATC

pantoprazole; systemic

2.2

112.0

3067

22927

A04AA01

ATC

ondansetron; systemic, rectal

3.2

111.7

491

1669

Z3231

NOMESCO Finland

Registered nurse

2.2

111.6

1319

7224

TQW11

NOMESCO Finland

Vacuum treatment of wound

9.2

108.5

133

149

JN4BD

NOMESCO Finland

Extensive body CT

2.9

107.6

551

2042

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

107.6

1569

9286

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

107.1

802

3605

T88.4

ICD-10 Finland

Failed or difficult intubation

+∞

106.7

102

J01DB01

ATC

cefalexin; oral

2.6

106.5

3695

30078

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

105.0

439

1446

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

103.1

789

3576

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.4

101.5

207

401

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

15.5

100.9

ZX120

NOMESCO Finland

Intravenous

2.9

99.6

520

1944

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

99.6

2026

13393

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.0

98.8

153

226

S18

ICPC

Laceration/cut

2.0

98.3

2004

13239

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

98.2

968

4891

X57

ICD-10 Finland

Unspecified privation

6.6

97.2

159

249

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

96.3

1933

12676

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

95.9

925

4626

R4110

NOMESCO Finland

Physiotherapy

2.1

95.6

1287

7333

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

95.4

1123

6081

WX892

NOMESCO Finland

Monitored bed care

3.2

95.3

410

1372

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.2

93.1

256

634

H02AB02

ATC

dexamethasone; systemic

2.6

92.0

610

2574

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.7

91.3

545

2182

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

91.1

501

1922

R51.80

ICD-10 Finland

Headache

2.3

90.9

826

4019

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

89.3

1380

8226

Y60

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

35.4

89.0

R11

ICD-10 Finland

Nausea and vomiting

2.8

88.0

490

1891

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

87.2

931

4832

R06AE07

ATC

cetirizine; oral

1.9

87.1

2066

14161

A02BC05

ATC

esomeprazole; systemic

1.9

86.0

1840

12189

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

85.4

496

1955

N06AX21

ATC

duloxetine; oral

2.5

85.3

624

2753

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

4.6

84.8

207

467

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

84.4

960

5100

P01AB01

ATC

metronidazole; oral, rectal

1.9

84.2

1810

11985

R53

ICD-10 Finland

Malaise and fatigue

2.0

84.1

1150

6540

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

83.8

600

2620

A46

ICD-10 Finland

Erysipelas

2.4

83.8

661

3017

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

4.0

83.0

249

657

B01AB10

ATC

tinzaparin; parenteral

2.7

82.3

501

2021

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.2

81.5

344

1135

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

80.4

1140

6551

C07AB07

ATC

bisoprolol; oral

1.8

80.3

2022

14002

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

79.5

1388

8557

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

79.4

867

4522

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

169.2

79.4

R60.0

ICD-10 Finland

Localized oedema

2.4

79.2

592

2632

R03AC02

ATC

salbutamol; inhalant

1.8

79.1

2458

18113

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.4

79.0

623

2838

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.7

77.6

457

1811

WX002

NOMESCO Finland

Sedation and analgesia

2.1

77.4

873

4606

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

77.2

1868

12734

N05CF01

ATC

zopiclone; oral

1.9

76.4

1424

8944

A04AA02

ATC

granisetron; systemic, transdermal

3.0

76.1

352

1224

Z3226

NOMESCO Finland

Physiotherapist

2.1

75.9

843

4418

JAH00

NOMESCO Finland

Laparotomy

5.1

75.4

163

332

ZXE00

NOMESCO Finland

One hour or less

1.8

75.1

1718

11485

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

74.8

267

793

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.8

74.1

236

649

UKC02

NOMESCO Finland

Cystoscopy

2.3

73.7

682

3320

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

193.4

73.4

ZXA05

NOMESCO Finland

Left side

2.0

72.1

1051

6065

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

71.8

1159

6920

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

71.8

736

3731

N05AH04

ATC

quetiapine; oral

2.1

71.5

840

4486

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.1

71.3

312

1050

WZC30

NOMESCO Finland

Teaching

2.2

71.2

732

3714

L50.0

ICD-10 Finland

Allergic urticaria

4.3

71.0

189

456

M79.6

ICD-10 Finland

Pain in limb

1.8

70.8

1836

12679

J01MA14

ATC

moxifloxacin; systemic

2.6

70.6

454

1876

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

70.1

1651

11073

E0000UV, ,

ATC

1.8

70.1

1854

12866

N06AX11

ATC

mirtazapine; oral

1.8

68.8

1508

9887

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

11.1

68.6

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.3

68.6

274

873

ZXA00

NOMESCO Finland

Right side

1.9

68.4

1113

6648

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

68.3

3099

25040

N03AX09

ATC

lamotrigine; oral

3.2

68.1

281

913

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.4

67.7

257

793

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

67.4

490

2143

L50.9

ICD-10 Finland

Urticaria, unspecified

3.5

67.1

241

718

XX3DW

NOMESCO Finland

Time consuming IT work

2.4

67.0

514

2303

N06AX16

ATC

venlafaxine; oral

2.1

67.0

701

3575

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.8

65.9

153

331

J01FA06

ATC

roxithromycin; oral

1.7

65.6

1757

12168

N05BA04

ATC

oxazepam; oral

1.9

65.6

1177

7239

M54.5

ICD-10 Finland

Low back pain

1.8

65.3

1591

10720

Y65.8

ICD-10 Finland

Other specified misadventures during surgical and medical care

172.7

65.2

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

65.1

1216

7568

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.5

64.5

235

706

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

6.2

64.3

110

180

H02AB07

ATC

prednisone; oral

2.2

63.9

646

3245

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.3

63.7

249

782

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.3

63.6

168

403

S97

ICPC

Chronic ulcer skin

3.1

63.4

279

941

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

89.0

63.1

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

62.5

460

2021

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.0

62.0

284

980

L28

ICPC

Limited function/disability (L)

2.0

61.6

754

4068

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.7

61.4

197

544

N05BA01

ATC

diazepam; systemic, rectal

2.2

61.3

609

3036

JAH01

NOMESCO Finland

Laparoscopy

3.3

61.2

236

735

SPAT1263

SPAT

Sampling

1.7

61.1

1821

12914

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

60.4

1003

5995

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.4

60.2

223

677

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.2

60.1

540

2584

A06AD11

ATC

lactulose; oral

2.1

59.7

628

3199

Z2446

NOMESCO Finland

Social worker

2.7

59.6

333

1280

J46

ICD-10 Finland

Status asthmaticus

3.9

58.7

177

468

SPAT1153

SPAT

Removal of sutures

1.8

58.6

1314

8586

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.2

58.5

121

237

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

58.3

806

4528

R42

ICD-10 Finland

Dizziness and giddiness

1.9

58.3

992

5966

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

57.9

1232

7924

R03DC03

ATC

montelukast; oral

2.0

57.5

788

4413

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

57.2

528

2551

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

57.1

709

3836

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

56.7

618

3187

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

20.7

56.6

WW500

NOMESCO Finland

Blood transfusion

3.4

56.3

214

660

R02

ICPC

Shortness of breath/dyspnoea

2.1

56.3

585

2962

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

56.2

639

3347

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

56.2

667

3549

SPAT1255

SPAT

Intravenous administration of medicine

2.7

56.0

324

1267

SPAT1301

SPAT

No procedures

1.7

55.7

1332

8839

B01AA03

ATC

warfarin; systemic

2.0

55.7

732

4036

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

55.3

345

1400

H02AB04

ATC

methylprednisolone; systemic

2.0

55.0

657

3502

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.7

54.4

133

I50.9

ICD-10 Finland

Heart failure, unspecified

2.2

54.2

528

2605

J01XX08

ATC

linezolid; systemic

17.8

54.1

R52.2

ICD-10 Finland

Other chronic pain

3.3

53.9

208

648

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

53.7

569

2899

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

53.3

593

3076

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

274.4

53.3

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.4

52.9

404

1799

J01AA02

ATC

doxycycline; systemic

1.8

52.9

3271

27644

J01EA01

ATC

trimethoprim; systemic

1.8

52.8

1152

7431

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

52.6

2219

16987

A02BC01

ATC

omeprazole; systemic

1.7

52.2

1156

7484

A41.9

ICD-10 Finland

Sepsis, unspecified

3.6

52.2

174

493

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.6

51.6

318

1282

R33

ICD-10 Finland

Retention of urine

2.6

51.3

321

1303

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.9

50.8

253

914

GD1AD

NOMESCO Finland

Thorax CT examination

2.8

50.7

274

1033

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.8

50.7

163

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.2

50.7

213

698

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

50.7

1097

7047

N06AA09

ATC

amitriptyline; systemic

2.3

50.5

437

2052

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

7.7

50.5

A28

ICPC

Limited function/disability NOS

2.0

50.5

669

3690

J01DA01

ATC

[U] cefalexin

1.6

50.0

2590

20734

T88.1

ICD-10 Finland

Other complications following immunization, not elsewhere classified

109.4

49.9

S06.0

ICD-10 Finland

Concussion

2.1

49.9

496

2463

L03AA14

ATC

lipegfilgrastim; parenteral

4.3

49.5

129

306

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

49.5

401

1831

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

49.5

1503

10556

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.8

49.3

254

934

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.5

49.1

320

1325

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.0

49.1

625

3398

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

48.8

855

5155

Z2221

NOMESCO Finland

Medical doctor

1.7

48.4

1168

7715

R52.9

ICD-10 Finland

Pain, unspecified

2.2

48.4

451

2182

SPAT1229

SPAT

Assessment of need for aid

2.4

48.2

343

1479

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

48.2

2084

15921

N02BF01

ATC

gabapentin; oral

2.3

48.2

378

1702

G44.2

ICD-10 Finland

Tension-type headache

2.0

48.1

634

3485

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.0

48.1

221

763

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

4.0

48.0

137

348

WX882

NOMESCO Finland

High dependency care

3.9

47.9

142

371

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

47.8

417

1963

SPAT1254

SPAT

Administration of medicine

1.9

47.8

648

3597

N30.0

ICD-10 Finland

Acute cystitis

1.9

47.7

736

4262

N03AG01

ATC

valproic acid; systemic, rectal

2.6

47.6

293

1180

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

126.5

46.8

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.2

46.6

194

632

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

46.6

725

4207

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

46.6

325

1388

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.8

46.6

236

860

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

46.5

418

1992

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

46.3

914

5698

SPAT1260

SPAT

Consultation of another employee

1.8

46.3

758

4469

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.3

46.3

177

548

M25.5

ICD-10 Finland

Pain in joint

1.6

46.2

1359

9431

SPAT1262

SPAT

Handing over of treatment supplies

1.9

46.1

708

4091

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

237.5

46.1

J04AB02

ATC

rifampicin; systemic

9.6

46.0

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.0

45.8

130

329

B01AB04

ATC

dalteparin; parenteral

2.8

45.5

240

893

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

45.3

289

1183

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

45.2

873

5404

J02AC01

ATC

fluconazole; systemic

1.6

44.8

1706

12577

A02BC03

ATC

lansoprazole; oral

1.7

44.6

1170

7872

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

44.1

411

1986

128

Kela drug reimbursment

Cancers of female genital organs

4.2

43.8

117

283

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.5

43.7

300

1271

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

43.6

1273

8791

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.0

43.3

194

660

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

43.1

295

1248

N02BF02

ATC

pregabalin; oral

2.5

42.8

275

1129

T88.5

ICD-10 Finland

Other complications of anaesthesia

+∞

42.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.3

42.6

164

510

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.2

42.5

175

567

WX872

NOMESCO Finland

Intensive care

2.9

42.4

211

761

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.5

42.4

279

1159

TQW40

NOMESCO Finland

Remowal of suture of skin

2.4

42.3

305

1321

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

42.3

303

1309

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

42.2

279

1161

ZXA10

NOMESCO Finland

Bilateral

1.8

42.1

757

4578

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

69.2

42.1

J45

ICD-10 Finland

Asthma

2.0

41.9

469

2428

WX320

NOMESCO Finland

Spinalanesthesy

1.7

41.8

941

6064

N03AE01

ATC

clonazepam; systemic

2.5

41.8

276

1148

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.3

41.7

343

1573

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.4

41.7

308

1349

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.6

41.6

247

976

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

41.6

175

574

A04AA55

ATC

palonosetron, combinations; systemic

2.9

41.5

197

692

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

41.4

1157

7883

WX213

NOMESCO Finland

Lower leg blockade

8.2

41.4

L04AX01

ATC

azathioprine; systemic

2.8

41.4

213

782

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.0

41.3

188

645

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

41.1

366

1734

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.2

41.1

390

1896

R03BB04

ATC

tiotropium bromide; inhalant

2.1

40.9

413

2057

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

40.9

770

4718

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

40.8

2281

18196

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

40.7

951

6185

T78.3

ICD-10 Finland

Angioneurotic oedema

4.7

40.6

203

Z51.5

ICD-10 Finland

Palliative care

2.3

40.5

328

1494

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.3

40.5

156

485

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.3

40.5

321

1449

M48.0

ICD-10 Finland

Spinal stenosis

2.0

40.5

477

2514

J01FA10

ATC

azithromycin; systemic

1.5

40.4

2422

19598

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.5

40.4

270

1129

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

40.2

419

2111

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.4

40.2

100

229

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

40.2

288

1244

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.6

39.6

207

A01

ICPC

Pain general/multiple sites

2.1

39.6

400

1991

JN6AD

NOMESCO Finland

CT of torso and neck

4.4

39.6

101

236

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

39.2

316

1436

G47.3

ICD-10 Finland

Sleep apnoea

1.7

39.2

878

5638

R52.0

ICD-10 Finland

Acute pain

3.1

39.2

172

578

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

39.1

328

1516

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

4.5

38.5

212

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

38.4

360

1740

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.6

38.4

130

372

A03

ICPC

Fever

1.8

38.4

728

4461

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.7

38.4

121

330

L03AA13

ATC

pegfilgrastim; parenteral

2.7

38.4

212

808

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

38.3

1620

12110

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

5.7

38.3

126

I50.0

ICD-10 Finland

Congestive heart failure

2.4

38.2

275

1189

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.4

38.2

141

427

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.5

38.0

248

1026

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.6

37.9

234

942

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

5.9

37.8

117

L01BC06

ATC

capecitabine; oral

2.9

37.8

183

650

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

5.6

37.8

131

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

37.8

300

1355

M03BX02

ATC

tizanidine; oral

1.5

37.6

2544

20977

R01AD09

ATC

mometasone; nasal

1.5

37.5

1893

14677

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.3

37.3

315

1459

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

37.3

605

3538

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

37.2

393

1989

R10.0

ICD-10 Finland

Acute abdomen

3.1

37.0

162

544

H02AB09

ATC

hydrocortisone; systemic

3.4

36.9

132

392

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

36.8

245

1022

NF1AA

NOMESCO Finland

Hip X-ray examination

2.2

36.8

329

1561

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.0

36.7

464

2503

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

36.7

414

2146

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

36.6

488

2680

J01FA09

ATC

clarithromycin; systemic

1.6

36.5

1288

9227

R4120

NOMESCO Finland

Occupational therapy

2.3

36.3

293

1332

XQ802

NOMESCO Finland

Epicutan test

2.7

36.1

205

792

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

35.9

331

1588

Z50.1

ICD-10 Finland

Other physical therapy

2.5

35.9

239

997

ZZA00

NOMESCO Finland

Split skin graft

3.7

35.7

113

309

SPAT1312

SPAT

General health counselling

1.6

35.7

1312

9474

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

35.7

168

588

L03

ICPC

Low back symptom/complaint

1.6

35.5

1138

7967

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

35.4

567

3299

R03BA02

ATC

budesonide; inhalant

1.7

35.4

746

4699

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.3

35.2

275

1232

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

35.2

983

6658

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

34.6

344

1700

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.3

34.6

263

1165

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.1

34.5

334

1633

R03AC03

ATC

terbutaline; inhalant

1.8

34.4

596

3549

WX704

NOMESCO Finland

Intubation

2.1

34.2

327

1591

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

10.4

34.2

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

34.2

803

5201

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.9

34.2

162

569

NH1AD

NOMESCO Finland

Ankle and foot CT

3.6

34.1

114

324

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

34.0

374

1919

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

33.9

422

2261

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.1

33.8

140

455

R06AX27

ATC

desloratadine; oral

1.6

33.8

1206

8632

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

33.8

1922

15162

N06AB10

ATC

escitalopram; oral

1.6

33.7

861

5695

A04

ICPC

Weakness/tiredness general

1.8

33.7

613

3702

A02BA02

ATC

ranitidine; systemic

1.7

33.7

743

4733

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.5

33.6

181

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

33.6

210

851

C03DA01

ATC

spironolactone; oral

1.9

33.5

454

2503

R03AK08

ATC

formoterol and beclometasone; inhalant

2.6

33.5

208

840

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

33.4

1095

7685

T88.0

ICD-10 Finland

Infection following immunization

+∞

33.4

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

33.3

257

1145

TK800

NOMESCO Finland

Hemodialysis

4.1

33.3

224

R52.1

ICD-10 Finland

Chronic intractable pain

6.0

33.2

Y96.9

ICD-10 Finland

Unspecified type of accident

4.1

33.2

229

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.3

33.1

124

379

J01CA04

ATC

amoxicillin; systemic

1.6

33.1

3418

30393

N03AX11

ATC

topiramate; oral

3.2

33.1

134

430

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.5

33.0

205

828

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

33.0

310

1499

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

32.9

290

1366

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.7

32.9

178

671

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.7

32.8

180

683

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

32.8

232

995

M05BX04

ATC

denosumab; parenteral

2.3

32.8

258

1160

D07AC01

ATC

betamethasone; topical

1.5

32.8

1429

10664

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

32.7

696

4387

W19

ICD-10 Finland

Unspecified fall

2.0

32.7

393

2081

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

7.4

32.6

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.2

32.6

215

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

32.5

345

1746

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.3

32.4

199

N05AH03

ATC

olanzapine; systemic

2.2

32.3

279

1304

L17

ICPC

Foot/toe symptom/complaint

1.6

32.3

1124

7988

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

32.2

465

2615

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.9

32.2

243

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.2

32.2

204

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.7

32.1

104

289

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

5.2

32.1

129

R55

ICD-10 Finland

Syncope and collapse

1.9

32.0

430

2363

N06AB04

ATC

citalopram; systemic

1.6

32.0

846

5637

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

31.9

272

1264

L50.8

ICD-10 Finland

Other urticaria

3.5

31.8

108

310

R07.3

ICD-10 Finland

Other chest pain

1.9

31.8

417

2273

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

31.7

726

4663

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

31.7

337

1707

C07AB02

ATC

metoprolol; systemic

1.7

31.7

740

4778

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

6.9

31.4

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

31.2

701

4477

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

31.2

216

917

C08CA01

ATC

amlodipine; oral

1.5

31.1

1389

10390

B02AA02

ATC

tranexamic acid; systemic

1.7

31.1

620

3836

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

31.1

249

1128

130

Kela drug reimbursment

Malignant tumour

2.0

31.0

336

1713

N05CD07

ATC

temazepam; oral

1.9

31.0

437

2439

E66.8

ICD-10 Finland

Other obesity

2.3

30.9

244

1098

R03BA05

ATC

fluticasone; inhalant

1.6

30.8

743

4832

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

30.8

2951

25564

Y60.0

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation

85.7

30.8

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

30.7

362

1902

L50.3

ICD-10 Finland

Dermatographic urticaria

3.5

30.7

105

303

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

9.5

30.6

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

30.5

768

5047

W84

ICD-10 Finland

Unspecified threat to breathing

10.7

30.4

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

30.3

450

2551

ZY010

NOMESCO Finland

Hospital outpatient

2.3

30.3

232

1030

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

30.3

208

880

K02.1

ICD-10 Finland

Caries of dentine

1.4

30.3

2384

19853

D01

ICPC

Abdominal pain/cramps general

1.8

30.1

495

2897

C07AA05

ATC

propranolol; systemic

1.6

30.0

838

5647

SPAT1216

SPAT

Assessment of functional ability

1.7

30.0

587

3610

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

30.0

2219

18253

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

30.0

285

1383

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

29.9

227

1004

M79.1

ICD-10 Finland

Myalgia

1.7

29.9

606

3764

XKD00

NOMESCO Finland

Uroflowmetry

1.8

29.8

507

2997

E87.6

ICD-10 Finland

Hypokalaemia

2.8

29.7

150

545

L04AA13

ATC

[U] leflunomide

3.1

29.7

122

395

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

29.7

372

1996

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.6

29.6

174

684

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.1

29.6

127

422

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.5

29.6

105

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.0

29.5

209

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

29.5

220

966

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

29.5

291

1433

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.4

29.4

210

904

N03AF02

ATC

oxcarbazepine; oral

2.8

29.4

150

548

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

29.4

379

2053

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

29.4

514

3062

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.5

29.3

192

795

E86

ICD-10 Finland

Volume depletion

3.3

29.3

109

332

HA1AA

NOMESCO Finland

X-ray mammography

2.0

29.2

330

1707

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

29.2

839

5688

SPAT1104

SPAT

Monitoring of emergency patient

2.1

29.2

274

1323

N06AA10

ATC

nortriptyline; systemic

3.3

29.2

109

333

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.9

29.0

138

486

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.8

29.0

152

564

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

29.0

183

745

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

28.9

266

1275

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

28.9

849

5786

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.9

28.8

390

2146

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

28.7

1598

12434

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

4.5

28.7

154

ZZF00

NOMESCO Finland

Graft of adipose tissue

5.9

28.7

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

28.6

406

2268

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

28.6

178

720

M04AA01

ATC

allopurinol; systemic

1.8

28.5

440

2523

L04AA06

ATC

mycophenolic acid; systemic

3.7

28.5

246

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

28.4

1078

7768

R51.81

ICD-10 Finland

Facial pain NOS

3.1

28.4

123

411

A07AA09

ATC

vancomycin; oral

4.5

28.2

156

R96

ICPC

Asthma

1.9

28.2

396

2204

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

4.5

28.2

152

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.2

28.1

113

361

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.1

28.0

270

1318

C09CA06

ATC

candesartan; oral

1.5

27.9

914

6376

R06AE09

ATC

levocetirizine; oral

1.7

27.9

604

3814

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.6

27.8

255

NHQ40

NOMESCO Finland

Amputation of toe

4.8

27.8

130

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.2

27.8

243

1141

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

27.7

161

629

R31

ICD-10 Finland

Unspecified haematuria

1.9

27.6

355

1919

M89.0

ICD-10 Finland

Algoneurodystrophy

5.2

27.6

108

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

27.6

204

892

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

5.1

27.5

116

N05AA02

ATC

levomepromazine; systemic

2.5

27.4

170

686

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.2

27.3

177

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

27.3

830

5691

B01AC04

ATC

clopidogrel; oral

1.7

27.1

553

3434

SPAT1310

SPAT

Counselling related to known health issue

1.5

27.1

1239

9257

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.9

27.0

132

472

A10AB05

ATC

insulin aspart; parenteral

2.0

26.9

298

1530

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

26.7

178

743

A92

ICPC

Allergy/allergic reaction NOS

2.7

26.6

146

555

M03BX01

ATC

baclofen; systemic

3.4

26.5

288

A41.8

ICD-10 Finland

Other specified sepsis

3.8

26.2

214

XF404

NOMESCO Finland

Ambulatory ECG

1.9

26.2

337

1823

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

26.0

529

3282

G43.3

ICD-10 Finland

Complicated migraine

3.5

26.0

267

WX290

NOMESCO Finland

Other blockage of nerve

1.4

26.0

1855

15018

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.0

25.9

290

1494

N03AF01

ATC

carbamazepine; oral, rectal

2.3

25.9

207

936

J01CF05

ATC

flucloxacillin; systemic

2.1

25.9

242

1166

K92.1

ICD-10 Finland

Melaena

2.3

25.9

198

879

A01AB09

ATC

miconazole; local oral

1.9

25.9

343

1873

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

25.8

233

1107

M54.1

ICD-10 Finland

Radiculopathy

2.4

25.7

175

738

TGC00

NOMESCO Finland

Bronchial lavation

3.0

25.6

111

371

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

8.2

25.6

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

7.8

25.5

R03BA08

ATC

ciclesonide; inhalant

1.9

25.5

359

1999

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

25.5

876

6162

A04AD12

ATC

aprepitant; systemic

3.2

25.4

103

331

L04AX03

ATC

methotrexate; systemic

1.8

25.4

388

2216

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

25.4

304

1604

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

25.4

1013

7351

M01AE02

ATC

naproxen; oral, rectal

1.4

25.3

2270

19077

R01AD58

ATC

fluticasone, combinations; nasal

1.5

25.3

986

7120

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.4

25.3

182

787

EBA00

NOMESCO Finland

Extraction of tooth

1.4

25.2

1389

10719

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

25.2

187

819

SPAT1167

SPAT

Insertion of urinary catheter

2.9

25.1

121

429

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

25.1

1556

12264

R01AD08

ATC

fluticasone; nasal

1.5

25.1

1138

8467

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.1

25.1

242

1181

Z71.8

ICD-10 Finland

Other specified counselling

1.5

25.0

1199

9017

M01AH05

ATC

etoricoxib; oral

1.4

24.9

2426

20648

Z00.0

ICD-10 Finland

General medical examination

1.6

24.9

737

5011

N02AC04

ATC

dextropropoxyphene; oral

2.7

24.9

138

527

M01AH01

ATC

celecoxib; oral

1.6

24.9

670

4458

R03BA01

ATC

beclometasone; inhalant

1.7

24.8

552

3502

TJF80

NOMESCO Finland

Ostomy education

5.3

24.8

L01BA01

ATC

methotrexate; systemic

2.5

24.8

156

634

ZXD35

NOMESCO Finland

Usual procedure

2.7

24.8

135

511

R06AX22

ATC

ebastine; oral

1.6

24.7

690

4628

WX730

NOMESCO Finland

Conventional respirator

4.0

24.7

173

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

24.6

531

3342

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.2

24.6

224

1068

T90

ICPC

Diabetes non-insulin dependent

1.5

24.6

835

5852

L04AD01

ATC

ciclosporin; systemic

3.4

24.6

257

G50.1

ICD-10 Finland

Atypical facial pain

3.3

24.5

282

A01AB04

ATC

amphotericin B; local oral

2.3

24.5

191

855

R03AC12

ATC

salmeterol; inhalant

2.3

24.5

184

811

WX702

NOMESCO Finland

Supraglottic ventilation device

2.2

24.5

221

1051

207

Kela drug reimbursment

Chronic arrhythmias

1.7

24.4

525

3301

SPAT1240

SPAT

Therapeutic discussion

1.8

24.4

429

2553

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.0

24.4

276

1428

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.7

24.3

127

471

ZZH31

NOMESCO Finland

Bone allograft, small pieces

7.9

24.3

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.8

24.2

126

466

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

24.2

440

2644

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

24.1

410

2416

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.6

24.1

144

571

WVA20

NOMESCO Finland

Medicine administration

2.9

24.0

114

401

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.6

24.0

137

531

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

24.0

895

6394

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.7

24.0

204

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.7

23.9

132

503

K65.0

ICD-10 Finland

Acute peritonitis

5.0

23.9

103

JFB00

NOMESCO Finland

Partial resection of small intestine

4.0

23.9

173

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.3

23.9

143

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

23.9

192

871

B01AF02

ATC

apixaban; oral

1.7

23.8

436

2626

M01AH02

ATC

rofecoxib; oral

1.7

23.7

456

2783

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

23.7

1644

13179

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.1

23.7

314

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

23.7

296

1585

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.4

23.6

172

748

B03XA02

ATC

darbepoetin alfa; parenteral

3.3

23.6

264

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.7

23.5

202

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

23.5

208

981

K30

ICD-10 Finland

Functional dyspepsia

1.7

23.5

447

2719

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.8

23.5

119

434

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.2

23.4

285

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

23.4

202

943

K07.60

ICD-10 Finland

Snapping jaw

2.1

23.3

226

1105

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

23.2

539

3454

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

23.2

253

1291

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.3

23.2

142

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.4

23.2

252

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

23.2

210

1000

TAB00

NOMESCO Finland

Lumbar puncture

2.2

23.1

190

870

L12

ICPC

Hand/finger symptom/complaint

1.6

23.1

625

4158

D11

ICPC

Diarrhoea

1.7

23.1

467

2889

QBJ30

NOMESCO Finland

Correction of abdominal apron

5.4

23.0

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

23.0

157

663

B34.9

ICD-10 Finland

Viral infection, unspecified

2.6

23.0

131

508

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

22.9

500

3153

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.2

22.9

193

893

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

22.9

191

880

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.7

22.9

493

3100

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.5

22.9

123

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.6

22.9

132

515

NG1AD

NOMESCO Finland

Knee CT examination

4.0

22.8

161

R05

ICD-10 Finland

Cough

1.5

22.8

827

5867

HAC20

NOMESCO Finland

Total mastectomy

2.4

22.8

163

703

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.1

22.8

216

1047

NF3AA

NOMESCO Finland

Femur X-ray examination

3.4

22.6

251

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.2

22.6

198

930

A10BA02

ATC

metformin; oral

1.5

22.5

992

7313

A99

ICPC

Disease/condition unspecnature/site

1.8

22.5

359

2075

L01

ICPC

Neck symptom/complaint

1.6

22.5

618

4123

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

22.5

165

720

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

22.5

807

5712

M54.2

ICD-10 Finland

Cervicalgia

1.9

22.4

319

1780

R05

ICPC

Cough

1.5

22.4

924

6723

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

22.4

459

2846

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.8

22.4

365

2123

ZX112

NOMESCO Finland

Subcutaneous

3.1

22.4

314

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

22.4

237

1197

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.5

22.4

137

550

N05AX12

ATC

aripiprazole; systemic

2.3

22.4

167

734

J05AB11

ATC

valaciclovir; oral

1.6

22.2

556

3627

E000001, ,

ATC

1.5

22.2

765

5365

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.2

22.2

269

K08.3

ICD-10 Finland

Retained dental root

1.9

22.2

281

1510

ZY000

NOMESCO Finland

Hospital inpatient

3.7

22.2

187

R4190

NOMESCO Finland

Nutritional therapy

2.4

22.2

149

625

NGC30

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, special prosthesis

24.0

22.1

J20

ICD-10 Finland

Acute bronchitis

1.7

22.1

393

2344

L86

ICPC

Back syndrome with radiating pain

2.0

22.0

236

1197

Z00.8

ICD-10 Finland

Other general examinations

1.9

22.0

305

1688

SFA10

NOMESCO Finland

One-surface restoration

1.4

22.0

2157

18222

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.4

21.9

154

659

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.5

21.9

217

D07AC13

ATC

mometasone; topical

1.4

21.9

1095

8261

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.2

21.9

S01

ICPC

Pain/tenderness of skin

2.2

21.8

186

864

G04CA02

ATC

tamsulosin; oral

1.5

21.8

681

4674

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.1

21.8

222

1105

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.4

21.8

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

6.4

21.8

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.5

21.7

133

534

N03AX14

ATC

levetiracetam; systemic

2.7

21.7

120

458

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.7

21.7

389

2326

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

6.7

21.7

JN4CD

NOMESCO Finland

Very extensive body CT

2.5

21.6

140

577

D07AA02

ATC

hydrocortisone; topical

1.6

21.6

537

3496

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.9

21.6

342

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

21.6

352

2048

S29

ICPC

Skin symptom/complaint other

1.5

21.6

712

4946

L02BG04

ATC

letrozole; oral

1.9

21.6

282

1532

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

21.5

334

1914

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

21.5

127

501

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

21.5

247

1284

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

21.5

312

1752

N01

ICPC

Headache

1.7

21.5

454

2838

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

21.4

356

2082

J05AB01

ATC

aciclovir; systemic

1.5

21.4

836

6012

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.4

21.3

147

624

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

21.2

1014

7579

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.1

21.2

200

968

ZXC40

NOMESCO Finland

Use of ultrasound

5.1

21.2

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.3

21.1

164

733

Z2445

NOMESCO Finland

Psychologist

2.3

21.1

168

759

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

21.1

197

949

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

21.1

1110

8442

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

21.1

219

1098

P01BA02

ATC

hydroxychloroquine; oral

1.8

21.1

325

1859

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

21.1

155

677

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

21.1

211

1044

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.4

21.1

150

646

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

21.0

149

640

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

21.0

239

1238

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.2

21.0

263

K08.80

ICD-10 Finland

Toothache NOS

1.8

21.0

347

2026

R00.2

ICD-10 Finland

Palpitations

1.8

20.9

316

1796

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.9

20.9

343

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.6

20.9

195

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.4

20.9

224

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

20.8

426

2639

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

+∞

20.8

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.2

20.8

182

855

127

Kela drug reimbursment

Transplant complication

3.8

20.8

168

I20.09

ICD-10 Finland

Unstable angina

2.1

20.7

192

922

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.0

20.7

246

1294

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

20.7

919

6772

M54.6

ICD-10 Finland

Pain in thoracic spine

1.9

20.7

290

1611

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

5.7

20.7

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

20.6

103

373

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.1

20.6

192

924

N18.0

ICD-10 Finland

End-stage renal disease

5.0

20.6

M01AB05

ATC

diclofenac; systemic, rectal

1.4

20.6

2571

22443

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.9

20.6

335

T81.7

ICD-10 Finland

Vascular complications following a procedure, not elsewhere classified

211.0

20.6

NFC00

NOMESCO Finland

Exchange of a loose part of prosthesis in hip joint

211.0

20.6

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

20.6

386

2337

N05CF02

ATC

zolpidem; oral

1.5

20.5

658

4540

SAA04

NOMESCO Finland

Special examination of mouth

2.0

20.5

218

1103

SPAT1097

SPAT

Recording of ECG

1.6

20.4

523

3428

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.8

20.4

161

M79.7

ICD-10 Finland

Fibromyalgia

2.3

20.4

152

668

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.1

20.4

139

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.4

20.4

147

637

C10AC01

ATC

colestyramine; oral

2.7

20.3

112

427

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

20.3

913

6740

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

20.3

122

486

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.0

20.3

295

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.9

20.2

153

R25.2

ICD-10 Finland

Cramp and spasm

2.7

20.2

106

394

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

20.2

540

3575

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.4

20.2

219

H03AA01

ATC

levothyroxine sodium; systemic

1.4

20.2

919

6799

B02.9

ICD-10 Finland

Zoster without complication

1.9

20.2

247

1313

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.0

20.2

AN1

Coronary angiography

1.7

20.1

354

2105

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

2.8

20.1

104

384

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

20.1

196

961

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.5

20.0

191

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.7

20.0

177

D07AB08

ATC

desonide; topical

1.7

20.0

409

2533

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.0

20.0

292

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

20.0

310

1776

R01AD12

ATC

fluticasone furoate; nasal

1.4

20.0

1232

9615

A29

ICPC

General symptom/complaint other

1.6

20.0

455

2898

D02

ICPC

Abdominal pain epigastric

1.9

20.0

244

1296

E000006, ,

ATC

1.9

19.9

263

1433

SPAT1279

SPAT

Preparation of immediate hospitalisation

4.3

19.9

120

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.3

19.9

155

694

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.2

19.9

164

752

C01DA14

ATC

isosorbide mononitrate; oral

1.6

19.9

477

3077

A10BH05

ATC

linagliptin; oral

2.2

19.9

178

844

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

19.8

137

582

115

Kela drug reimbursment

Breast cancer

1.8

19.8

321

1863

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.3

19.8

154

689

J01FA15

ATC

telithromycin; oral

1.7

19.8

381

2322

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.9

19.7

332

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

73.8

19.7

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

4.4

19.6

109

EB1WA, ,

NOMESCO Finland

5.2

19.5

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

7.8

19.5

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.4

19.5

209

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

19.5

1129

8710

N06AX26

ATC

vortioxetine; oral

1.8

19.5

284

1596

R03AK11

ATC

formoterol and fluticasone; inhalant

2.7

19.5

108

413

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.0

19.5

225

1172

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

7.1

19.5

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

19.5

168

785

N17

ICPC

Vertigo/dizziness

1.6

19.5

458

2940

UJD02

NOMESCO Finland

Gastroscopy

2.1

19.4

179

858

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

19.4

279

1563

M54.3

ICD-10 Finland

Sciatica

1.9

19.4

231

1217

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.9

19.3

248

1339

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

3.0

19.3

282

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.9

19.3

230

1212

J01CA08

ATC

pivmecillinam; oral

1.4

19.3

1622

13287

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

15.6

19.2

SPAT1325

SPAT

Vaccination

1.4

19.2

1230

9648

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.0

19.2

203

1025

N06AB06

ATC

sertraline; oral

1.6

19.2

440

2806

ZX070

NOMESCO Finland

Intensity modified radiotherapy

3.2

19.1

237

A07AA02

ATC

nystatin; oral

2.0

19.1

219

1138

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

19.1

202

1020

J01FA01

ATC

erythromycin; systemic

1.6

19.1

533

3563

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.0

19.0

279

ZX114

NOMESCO Finland

Intramuscular

3.4

19.0

198

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

19.0

122

502

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

3.6

19.0

179

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.9

18.9

249

1355

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

18.9

410

2577

L04AB04

ATC

adalimumab; parenteral

2.7

18.9

368

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

18.9

475

3097

N04AA02

ATC

biperiden; systemic

3.0

18.9

275

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.1

18.9

125

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.5

18.9

117

473

OAB50, ,

SPAT

2.0

18.8

203

1032

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.4

18.8

127

534

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.8

18.8

341

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.6

18.8

107

415

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.2

18.8

117

G54.0

ICD-10 Finland

Brachial plexus disorders

2.6

18.8

108

421

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

+∞

18.8

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

5.0

18.7

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

1931

7991

3.56

307.65

6.4

3.8

—

(3042936) Bacteria identified in Isolate by Culture

1144

3746

3.79

294.30

2.9

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2896

17204

3.08

260.32

9.9

5.7

10.23

11.26

umol/l

7.34

2792

16243

(3007853) Bacteria identified in Skin by Aerobe culture

996

3377

3.53

238.24

2.2

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2531

14603

2.77

228.71

18.9

12.9

1.22

1.24

inr

0.38

803

4313

(3013650) Neutrophils [#/volume] in Blood by Automated count

3089

19834

2.96

225.28

14.9

8.5

4.19

4.02

e9/l

3.49

2805

17256

(3013826) Glucose [Moles/volume] in Serum or Plasma

3047

19467

2.92

223.47

8.6

4.1

6.70

6.64

mmol/l

0.92

2932

18063

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2719

16412

2.77

222.22

10.6

5.9

1.21

1.22

mmol/l

10.37

2314

13864

(3024561) Albumin [Mass/volume] in Serum or Plasma

2452

14068

2.72

221.60

7.2

4.3

34.56

35.90

g/l

24.16

2347

13037

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2514

14835

2.66

210.82

10.0

5.2

1.21

1.22

mmol/l

9.71

2388

13446

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1215

4994

2.99

207.31

2.3

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2645

16110

2.66

205.99

9.4

6.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1213

4999

2.98

205.79

5.3

3.2

0.81

0.82

mmol/l

2.23

1156

4661

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1948

10297

2.63

202.86

3.7

2.4

55.11

59.20

u/l

3.11

1837

9474

(3006315) Basophils [#/volume] in Blood

2735

17150

2.62

196.86

8.7

5.7

0.04

e9/l

0.21

2452

14807

(3001604) Monocytes [#/volume] in Blood

2730

17111

2.62

196.56

8.7

5.6

0.58

0.57

e9/l

1.10

2446

14788

(3013115) Eosinophils [#/volume] in Blood

2786

17760

2.60

191.43

9.1

5.8

0.19

e9/l

0.60

2540

15584

(3019198) Lymphocytes [#/volume] in Blood

2773

17651

2.60

190.91

8.8

5.7

1.86

1.94

e9/l

1.76

2536

15645

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3585

26371

3.12

177.84

13.2

6.8

81.52

77.19

u/l

7.27

3471

24793

(3003396) Base excess in Arterial blood by calculation

885

3302

3.11

176.28

10.6

6.6

0.98

1.03

mmol/l

0.13

733

2592

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2505

15622

2.44

173.59

3.5

2.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3229

22730

2.67

170.03

7.0

4.1

1413.83

1682.50

e6/l

0.14

298

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

888

3389

3.04

169.44

2.1

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

888

3411

3.02

167.33

2.1

1.7

—

(3018418) pH of Serum or Plasma

1794

9785

2.43

166.26

5.6

3.6

7.40

0.45

412

1813

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

871

3322

3.03

166.11

10.7

6.6

5.07

kpa

0.08

844

3151

(3044640) Blood type and Crossmatch panel - Blood

1862

10335

2.41

165.77

3.3

2.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

870

3321

3.03

165.63

10.7

6.6

12.49

12.51

kpa

0.03

845

3148

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

655

2125

3.45

163.59

2.1

1.6

—

(3026008) Bacteria identified in Urine by Culture

1836

10187

2.40

162.87

4.2

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

1684

9034

2.42

160.75

4.3

2.9

0.45

0.41

e6/l

0.20

1399

6785

(3002582) Erythrocytes [#/volume] in Urine

1788

9872

2.38

159.62

4.5

3.0

53.04

94.12

e6/l

1.41

1483

7486

(3016502) Oxygen saturation in Arterial blood

791

2922

3.09

159.03

11.1

7.0

95.89

95.65

0.55

772

2806

(3000850) Epithelial cells [#/volume] in Urine

1383

6831

2.51

157.87

3.4

2.4

6.67

6.23

e6/l

0.47

1282

6085

(3019069) Monocytes/100 leukocytes in Blood

2519

16193

2.33

156.38

9.5

6.1

8.44

8.46

0.15

2402

15146

(3018095) Leukocytes [#/volume] in Urine

2017

11807

2.33

156.31

5.1

3.4

66.33

104.85

e6/l

2.48

1586

8137

(3006504) Eosinophils/100 leukocytes in Blood

2502

16097

2.32

154.16

9.1

5.8

2.80

2.82

0.18

2387

15028

(36304419) Bacteria [Presence] in Urine

1646

8874

2.38

153.90

4.3

2.8

—

(3022096) Basophils/100 leukocytes in Blood

2440

15586

2.30

152.20

9.0

5.8

0.65

0.68

1.89

2318

14509

(3002173) Hemoglobin [Mass/volume] in Arterial blood

739

2697

3.10

151.21

11.8

7.3

119.61

122.91

g/l

4.27

730

2607

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1064

4740

2.65

149.61

2.8

2.1

29.42

29.64

0.65

1034

4590

(3003458) Phosphate [Moles/volume] in Serum or Plasma

942

3946

2.77

149.61

7.3

5.1

1.06

1.04

mmol/l

1.64

897

3644

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2045

12216

2.28

148.88

5.4

3.2

30.09

85.87

ng/l

0.77

1492

7793

(3002030) Lymphocytes/100 leukocytes in Blood

2550

16690

2.29

148.62

9.2

5.9

26.75

28.53

12.56

2440

15657

(3018010) Neutrophils/100 leukocytes in Blood

2511

16455

2.26

144.15

8.9

5.7

58.14

56.81

6.22

2399

15412

(3000991) Gas panel - Venous blood

679

2433

3.13

142.90

11.9

7.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

692

2553

3.04

138.13

10.3

6.4

1.30

1.36

mmol/l

0.59

675

2493

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

552

1793

3.38

136.41

11.8

8.4

0.68

0.69

0.21

546

1781

(3033658) Prothrombin time (PT) actual/Normal

1527

8353

2.28

134.07

6.4

3.5

90.29

91.99

1.80

1486

8133

(3020779) Urea [Moles/volume] in Serum or Plasma

688

2574

2.99

133.69

9.4

6.5

9.26

9.22

mmol/l

0.05

651

2453

(3026782) Osmolality of Urine

1276

6480

2.38

133.24

3.8

2.7

514.54

541.03

mosm/kgh2o

4.16

1159

5526

(3037467) Urinalysis macro (dipstick) panel - Urine

3228

23887

2.39

132.86

6.4

4.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

183

238

7.99

132.47

7.6

6.1

11.60

11.55

mg/l

0.05

167

222

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

546

1803

3.32

131.16

11.8

8.3

1.37

1.38

0.08

541

1794

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1696

9820

2.20

128.20

3.1

2.1

174.98

205.18

u/l

0.82

1631

9191

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1383

7418

2.27

125.79

2.3

1.7

1.16

1.11

mg/l

0.24

1095

5572

(3035350) Ketones [Presence] in Urine by Test strip

2491

16930

2.11

121.79

5.5

3.4

0.00

estimate

0.39

616

3315

(3021601) Nitrite [Presence] in Urine by Test strip

2487

16924

2.11

120.79

7.0

4.6

0.00

estimate

0.80

584

3136

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1423

7836

2.22

120.37

3.3

2.0

—

(3009261) Glucose [Presence] in Urine by Test strip

2502

17097

2.10

119.75

5.5

3.4

0.00

estimate

1.08

567

3050

(3015377) Calcium [Moles/volume] in Serum or Plasma

1844

11349

2.09

115.89

4.5

3.1

2.34

2.36

mmol/l

5.80

1698

10015

(3036481) Cortisol [Moles/volume] in Serum or Plasma

741

3096

2.68

115.75

2.9

2.1

359.97

372.03

nmol/l

0.78

704

2831

(3022948) Iron [Moles/volume] in Serum or Plasma

1019

4952

2.38

115.35

3.1

2.2

12.57

13.63

umol/l

3.95

965

4631

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1807

11105

2.08

113.34

4.7

3.1

34.08

36.12

u/l

0.41

1727

10559

(3004789) Transferrin [Mass/volume] in Serum or Plasma

952

4535

2.41

112.40

3.2

2.2

2.34

2.36

g/l

0.65

892

4193

(3021447) Carbon dioxide [Partial pressure] in Venous blood

681

2771

2.73

111.82

5.4

3.4

5.85

5.83

kpa

0.16

653

2687

(3012544) pH of Venous blood

693

2858

2.70

110.75

5.4

3.4

7.39

7.38

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

203

357

5.92

110.56

2.1

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

383

1124

3.64

109.98

2.6

1.9

3.27

2.14

ug/l

0.47

348

1003

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1497

8654

2.12

109.80

3.5

2.9

1500.76

1239.61

ng/l

1.17

1298

7364

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

894

4220

2.41

107.21

3.3

2.3

21.62

23.31

3.36

775

3619

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1450

8348

2.11

106.94

2.8

2.1

3.11

2.89

mg/l

2.58

1303

7123

(3002032) Base excess in Venous blood by calculation

670

2765

2.68

106.67

5.4

3.4

2.08

1.99

mmol/l

0.26

579

2329

(3015736) pH of Urine

2077

13652

2.01

105.88

4.9

3.2

5.86

5.87

0.01

140

1100

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

774

3438

2.52

105.87

5.0

4.1

241.37

242.78

u/l

0.10

743

3250

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

27.10

105.33

1.1

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

572

2226

2.81

101.79

1.6

1.3

311.74

203.33

u/ml

1.03

539

2057

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

678

2893

2.59

100.49

2.9

2.1

0.21

g/l

0.50

631

2702

(40758558) Short blood count panel - Blood

1457

8611

2.04

98.45

10.6

6.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3287

25813

2.15

97.28

5.8

3.8

13.98

11.52

mm/h

15.27

3110

23892

(3019060) Gas panel - Arterial blood

504

1883

2.90

96.55

7.0

4.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1032

5477

2.16

91.88

3.6

2.5

1.07

1.15

e6/l

0.26

638

3068

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2117

14460

1.91

91.88

2.8

2.2

74.30

77.23

nmol/l

5.24

1966

13051

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

429

1507

3.05

91.61

13.1

8.8

24.23

24.31

mmol/l

0.19

421

1463

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

477

1790

2.87

90.40

1.8

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

707

3225

2.43

90.17

4.4

3.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

555

2263

2.67

89.62

4.9

3.0

4.85

4.55

kpa

2.06

533

2186

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

271

722

3.94

89.19

1.8

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4056

35356

3.44

89.06

30.5

11.9

23.72

22.31

mg/l

2.25

3683

27329

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

428

1548

2.96

86.64

15.5

9.0

—

(3021589) Normoblasts [#/volume] in Blood

2192

15374

1.87

85.33

16.7

8.5

0.00

e9/l

0.18

1845

12506

(3029937) Albumin [Presence] in Urine by Test strip

1462

9010

1.94

84.96

6.2

3.8

0.00

estimate

0.10

560

3056

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

296

869

3.58

84.50

4.5

3.5

0.31

0.36

u/ml

2.01

174

490

(3005719) IgG [Mass/volume] in Serum or Plasma

580

2494

2.53

83.67

3.5

2.8

10.13

10.55

g/l

1.45

540

2277

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

262

713

3.85

83.60

1.8

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

467

1820

2.76

82.10

10.2

6.1

24.70

24.54

mmol/l

0.37

455

1715

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1916

13061

1.84

80.02

5.9

3.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

211

517

4.24

77.71

1.8

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

278

830

3.51

77.24

1.5

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

257

734

3.66

76.35

2.2

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

701

3417

2.26

75.68

3.4

2.5

1.79

1.76

0.40

643

3039

(3017181) Myelocytes/100 leukocytes in Blood

603

2763

2.37

75.23

4.8

4.1

0.99

0.85

0.74

280

884

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

935

5118

2.06

74.81

3.8

2.7

2.93

2.92

e6/l

0.00

539

2726

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

744

3738

2.20

74.47

3.9

2.6

7.47

7.79

umol/l

0.19

645

3216

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

227

606

3.90

74.35

6.5

5.1

268.73

709.04

iu/ml

0.95

(4035726) Immunohistochemistry procedure

611

2840

2.34

73.67

1.6

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1237

7497

1.91

73.54

1.7

1.5

20.44

20.63

nmol/l

0.16

1126

6389

(3019550) Sodium [Moles/volume] in Serum or Plasma

4054

35992

3.08

72.85

32.2

13.5

139.31

139.71

mmol/l

20.86

4016

35027

(3037522) Nuclear Ab [Titer] in Serum

879

4746

2.07

72.78

1.5

1.4

634.29

556.73

titre

0.45

182

990

(3020891) Body temperature

335

1163

3.04

72.59

6.9

4.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2165

15606

1.78

72.57

3.8

2.7

144.55

112.19

ug/l

3.11

2046

14518

(3023103) Potassium [Moles/volume] in Serum or Plasma

4058

36110

3.07

71.35

32.4

13.6

3.96

3.95

mmol/l

0.45

4016

35077

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

644

3110

2.26

70.77

3.0

2.2

36.27

53.32

u/l

0.57

573

2658

(3028026) IgM [Mass/volume] in Serum or Plasma

465

1962

2.54

69.20

2.2

1.9

1.30

1.34

g/l

0.13

437

1788

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1060

6210

1.94

69.15

4.9

3.3

246.88

437.66

ng/l

1.49

792

4616

(3019420) Tryptase [Mass/volume] in Serum or Plasma

117

191

6.27

68.60

2.0

1.5

15.09

8.05

ug/l

1.11

105

163

(3044889) 12 lead EKG panel

2995

23971

1.81

67.86

4.9

3.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

564

2635

2.31

66.82

4.9

4.1

0.14

0.11

0.40

241

756

(3004119) Hemoglobin [Mass/volume] in Venous blood

432

1790

2.57

66.68

4.8

2.8

126.20

129.93

g/l

2.67

417

1746

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

645

3201

2.19

65.97

5.3

3.8

59.95

24.44

ug/l

0.32

516

2565

(3011397) Hemoglobin [Presence] in Urine by Test strip

1264

7940

1.84

65.83

5.2

3.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

272

887

3.21

65.47

3.4

2.7

3.61

3.58

g/l

0.13

260

835

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

288

977

3.09

64.83

2.7

2.0

365.13

504.79

ug/l

0.63

279

905

(3009445) Proteinase 3 Ab [Units/volume] in Serum

354

1347

2.77

64.69

1.5

18.89

11.17

u/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

543

2535

2.31

64.32

2.8

2.5

65.76

66.65

g/l

1.86

499

2322

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

430

1810

2.53

64.13

2.0

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

541

2529

2.30

63.86

4.5

3.8

0.69

0.01

235

763

(3018405) Lactate [Moles/volume] in Arterial blood

294

1025

3.00

63.07

5.1

3.5

1.29

1.43

mmol/l

1.83

289

1012

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1901

13566

1.72

62.92

2.3

1.9

93.55

96.74

pmol/l

2.15

1094

6918

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

168

407

4.25

62.74

1.7

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

544

2569

2.28

62.62

3.8

2.2

5.66

7.03

ug/l

0.95

494

2240

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

194

527

3.81

61.91

1.6

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

279

971

3.00

59.99

2.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

336

1297

2.72

59.61

5.5

3.5

52.11

48.85

1.51

329

1279

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1007

6078

1.86

58.56

4.0

2.8

2.46

2.45

mmol/l

1.07

894

5332

(3019309) Folate [Moles/volume] in Red Blood Cells

978

5849

1.87

58.56

1.9

1.7

1253.02

1152.33

nmol/l

2.66

793

4418

(3023183) Ammonium ion [Moles/volume] in Plasma

211

632

3.46

58.17

3.3

2.9

33.31

36.12

umol/l

0.73

189

570

(3025159) Blasts/100 leukocytes in Blood

524

2510

2.24

58.06

5.0

4.1

0.09

0.37

0.85

202

633

(3052851) Hemolysis interference index of Serum or Plasma

265

913

3.03

57.98

3.7

2.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2899

23472

1.72

57.59

4.5

2.9

60.50

43.84

u/l

10.30

2768

21907

(3017143) Hepatitis C virus Ab [Presence] in Serum

734

4012

2.00

57.42

1.8

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

161

407

4.07

56.79

1.6

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1304

8598

1.74

55.84

3.3

2.5

4026.04

4663.21

umol/l

0.21

1151

7528

(3036489) Thrombin time

307

1177

2.73

55.11

3.0

2.1

21.00

21.17

0.31

273

1026

(3027273) Bicarbonate [Moles/volume] in Venous blood

345

1407

2.58

54.72

5.1

2.9

25.32

25.36

mmol/l

0.06

329

1361

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

168

452

3.83

54.33

1.5

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

281

1037

2.83

54.23

1.7

0.24

0.23

g/l

0.14

269

982

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

172

472

3.75

54.06

3.1

2.8

1691.11

1885.19

u/ml

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

285

1074

2.77

52.85

1.7

1.6

1.19

1.18

g/l

0.16

272

1018

(3023520) Reticulocytes [#/volume] in Blood

509

2502

2.17

52.64

2.7

2.5

70.63

69.58

e9/l

0.30

386

1877

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

151

387

4.01

52.27

1.5

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

325

1324

2.57

51.60

1.9

1.7

1.59

1.53

g/l

0.42

271

1148

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

175

502

3.59

51.52

1.8

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

175

502

3.59

51.52

1.8

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3276

27780

1.74

51.31

5.3

4.0

14.75

14.70

pmol/l

0.49

3067

25356

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

248

890

2.90

50.36

3.5

2.4

192.22

183.21

0.77

232

850

(3000475) Leukocytes [#/volume] in Synovial fluid

197

619

3.29

50.30

1.9

1.6

10282.68

8563.14

e6/l

0.38

134

451

(3027315) Oxygen [Partial pressure] in Blood

211

693

3.15

50.06

5.0

4.0

8.64

8.58

kpa

0.20

211

682

(3010421) pH of Blood

235

822

2.97

49.98

5.0

3.8

7.42

0.90

218

744

(3012501) Base excess in Blood by calculation

210

689

3.15

49.91

5.1

4.0

2.56

2.61

mmol/l

0.10

157

451

(3000494) Fungus identified in Specimen by Culture

689

3852

1.94

49.90

1.8

1.4

—

(3019150) Specific gravity of Urine by Refractometry

1128

7333

1.73

49.79

6.1

3.8

1.01

1.02

kg/l

2.54

145

1102

(3013290) Carbon dioxide [Partial pressure] in Blood

210

690

3.15

49.79

5.1

4.0

5.00

5.04

kpa

0.32

210

680

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

414

1923

2.28

49.07

5.2

3.7

5.27

5.18

kpa

1.23

392

1828

(3025941) Bacteria identified in Stool by Culture

410

1906

2.27

48.48

1.5

1.2

—

(40761535) Cells panel - Urine sediment

520

2657

2.09

48.43

5.0

3.2

—

(3009343) pH of Capillary blood

409

1901

2.27

48.38

5.1

3.8

7.43

7.41

1.26

230

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

399

1837

2.29

48.27

5.1

3.7

1.94

1.85

mmol/l

0.16

292

1363

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

260

979

2.76

48.23

3.1

2.5

91.06

92.80

0.53

252

941

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

132

326

4.15

48.05

1.7

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

749

4356

1.87

47.91

2.6

2.3

163.95

126.56

ug/g

1.60

611

3430

(3002256) Pathology report gross observation

746

4341

1.87

47.61

1.4

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

196

635

3.19

47.57

3.0

2.3

16.66

16.42

0.30

313

(40768804) Tissue Pathology biopsy report

1902

14259

1.60

47.33

2.5

2.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

273

1065

2.67

47.25

1.7

292.33

333.33

titre

0.08

(3007164) IgA [Mass/volume] in Serum or Plasma

1080

7031

1.71

46.99

1.8

1.4

2.34

2.35

g/l

0.10

705

4290

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

477

2386

2.12

46.92

4.4

3.5

97.25

82.68

ng/l

2.29

429

2059

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

516

2690

2.04

45.37

5.5

3.3

1.23

mmol/l

0.54

480

2308

(3013512) EKG study

1360

9474

1.64

45.35

4.7

3.6

—

(3002385) Erythrocyte distribution width [Ratio]

3509

30742

1.76

44.17

32.8

14.4

14.83

14.76

0.39

3482

30161

(3041096) Erythrocytes [Presence] in Urine by Automated

1330

9262

1.63

44.16

4.9

3.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1027

6707

1.70

43.69

2.0

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

501

2618

2.03

43.69

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

883

5539

1.75

43.45

1.8

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

417

2080

2.11

41.12

2.5

2.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

208

757

2.84

41.10

1.5

1.4

35.88

20.36

e6/l

0.44

170

582

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

208

758

2.83

41.00

1.6

1.4

4799.84

1552.67

e6/l

0.55

178

614

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3705

33188

1.82

40.50

24.9

11.3

83.41

82.86

ml/min/173m2

0.75

3263

27155

(1616796) Gas panel - Central venous blood

191

676

2.91

39.73

4.4

3.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

203

746

2.81

39.39

1.4

1.3

3.76

3.73

mmol/l

0.15

194

699

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2811

23581

1.55

39.13

3.7

3.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3673

32929

1.77

38.53

6.2

4.7

1.87

2.11

mu/l

1.31

3468

30302

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

477

2559

1.97

38.39

3.5

2.8

234.33

182.79

ng/l

0.87

439

2305

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

125

349

3.66

38.32

1.7

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

125

349

3.66

38.32

1.7

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

100

238

4.28

38.25

2.4

2.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4068

37772

2.34

38.05

18.1

9.4

26.50

25.85

u/l

1.47

4004

36420

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

182

647

2.89

37.55

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

182

647

2.89

37.55

1.5

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

216

841

2.65

37.46

1.7

1.5

9.90

16.01

iu/ml

—

(3022145) Colonoscopy Study observation

620

3652

1.81

37.32

1.4

1.3

—

(40761536) Microorganisms panel - Urine sediment

524

2932

1.90

37.14

6.1

3.6

—

(40768797) Stomach Pathology biopsy report

748

4676

1.73

36.60

1.3

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

225

4.29

36.57

1.6

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

133

401

3.39

36.28

2.3

1.8

89.97

89.90

0.05

133

396

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

183

667

2.82

36.06

3.9

3.6

59.63

57.28

1.43

183

667

(40761511) CBC panel - Blood by Automated count

4007

37088

2.12

36.03

26.4

11.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1157

8149

1.57

35.05

1.4

1.3

1.34

1.75

u/ml

0.48

307

2183

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

107

286

3.81

34.96

1.8

1.4

—

(3011412) CD3 cells [#/volume] in Blood

114

319

3.64

34.85

2.3

2.4

1.19

1.21

e9/l

0.06

288

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

164

4.83

34.81

2.1

2.6

93.36

98.10

0.52

153

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

101

263

3.91

34.25

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

101

263

3.91

34.25

1.8

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

101

263

3.91

34.25

1.8

1.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

256

3.93

33.90

2.3

2.2

76.42

72.00

2.06

243

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

373

1921

2.03

33.54

7.1

3.3

48.48

57.59

u/ml

0.45

360

1849

(3021901) Oxygen saturation in Capillary blood

153

531

2.95

32.98

3.1

2.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

150

516

2.98

32.84

1.4

1.6

0.57

0.78

g/l

2.70

117

398

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

112

5.60

32.81

1.1

1.2

115.20

108.51

1.39

103

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1026

7126

1.58

32.66

1.8

1.6

26117282.51

33014381.27

pmol/l

0.14

873

5949

(3051651) Icteric interference index of Serum or Plasma

177

4.53

32.66

3.6

2.9

—

(3044941) Cell count panel - Synovial fluid

127

399

3.25

32.45

1.7

1.3

—

(3023419) Bacteria identified in Sputum by Culture

137

451

3.10

32.38

3.4

2.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

177

673

2.70

32.17

1.6

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

1381

10265

1.51

32.13

3.7

3.1

7.33

7.52

mmol/l

0.72

1179

8706

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

188

751

2.57

30.95

1.5

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

142

490

2.96

30.93

3.5

3.4

1.65

1.59

0.09

130

441

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

896

6099

1.59

30.86

1.3

30.29

30.67

iu/ml

0.02

309

1976

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

409

2241

1.91

30.66

3.6

3.3

4.37

4.50

pmol/l

1.44

364

2013

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

111

333

3.39

30.55

1.9

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

217

4.02

30.48

1.9

1.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

121

5.18

30.17

1.2

0.31

0.29

g/l

0.90

100

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

103

301

3.48

29.54

1.9

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

222

979

2.34

29.47

1.4

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

233

3.83

29.18

2.7

2.4

679.58

750.37

e6/l

0.44

225

(3044290) Cell count panel - Cerebral spinal fluid

173

683

2.60

29.18

1.5

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

164

631

2.66

29.13

1.8

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

222

987

2.32

28.92

1.4

1.1

—

(3021788) Differential panel - Synovial fluid

131

449

2.98

28.89

1.9

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

102

301

3.45

28.82

3.5

2.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

282

1384

2.11

28.80

1.3

2.16

1.03

u/ml

0.26

125

(4062490) Immunoglobulin typing, IgG

107

328

3.32

28.48

1.5

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

140

4.70

28.23

2.8

1.7

112.54

164.42

umol/l

0.70

(3003694) ABO and Rh group [Type] in Blood

1318

9908

1.48

28.18

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

847

5798

1.57

28.17

1.3

1.2

9.66

11.13

u/ml

0.30

324

2303

(42529406) Shigella sp [Presence] in Stool by Culture

221

992

2.29

28.16

1.4

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

235

1087

2.23

27.86

4.4

3.3

491.45

4506.25

u/ml

0.86

206

911

(3024139) IgG subclass 3 [Mass/volume] in Serum

105

325

3.29

27.53

1.4

0.42

0.41

g/l

0.02

232

(3028192) IgG subclass 2 [Mass/volume] in Serum

105

325

3.29

27.53

1.4

2.81

2.96

g/l

0.34

235

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

141

517

2.79

27.50

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

972

6893

1.53

27.49

1.9

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

105

326

3.28

27.39

1.4

6.77

6.85

g/l

0.05

234

(3047181) Lactate [Moles/volume] in Blood

212

948

2.30

27.25

10.4

5.1

1.27

mmol/l

0.02

188

816

(3028707) Methadone [Presence] in Urine by Screen method

155

600

2.64

27.21

4.3

2.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

311

1636

1.97

26.21

3.3

2.6

0.31

0.29

e6/l

0.13

306

1584

(3006184) Hemoglobin [Mass/volume] in Capillary blood

162

658

2.52

25.78

2.6

2.1

128.93

130.18

g/l

0.22

123

484

(3003181) Sodium [Moles/volume] in Urine

139

524

2.71

25.72

2.3

1.4

66.32

63.58

mmol/l

0.28

111

427

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

183

3.98

25.31

4.6

2.8

39.63

43.07

0.70

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

441

2623

1.76

25.17

3.0

2.4

64.75

68.27

ml/min/173m2

1.07

208

1001

(3020682) Albumin/Creatinine [Ratio] in Urine

1297

9901

1.44

24.94

4.0

3.8

14.85

7.93

mg/mmol

3.41

834

6183

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

167

699

2.45

24.93

1.6

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

161

4.15

24.53

1.7

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

272

1402

2.00

24.28

1.9

37.84

39.38

u/l

0.69

249

1261

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

159

4.14

24.07

1.7

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

221

1058

2.15

24.05

1.8

1.5

14.79

0.93

iu/ml

0.46

218

(3036180) Methadone [Presence] in Urine

130

4.51

24.03

2.0

1.9

—

(3024928) Oxygen saturation in Venous blood

151

615

2.51

23.91

3.7

2.7

—

(3012516) Albumin [Mass/volume] in Urine

1236

9412

1.44

23.87

3.5

3.2

671.25

324.05

mg/l

1.23

815

5879

(3024891) Influenza virus A+B Ag [Presence] in Specimen

194

887

2.24

23.67

1.2

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

241

1201

2.07

23.60

2.5

2.3

7.56

7.38

g/l

0.81

217

1093

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

241

1201

2.07

23.60

2.5

2.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

618

4084

1.60

23.51

12.4

6.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

627

4164

1.59

23.35

2.2

1.7

1.57

1.43

4.26

539

3686

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

240

1200

2.06

23.30

2.5

2.3

3.66

3.64

g/l

0.06

216

1092

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

225

3.51

22.88

2.4

2.3

504.97

540.82

e6/l

0.20

190

(4200892) Spirometry reversibility

397

2354

1.76

22.83

1.5

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

219

1067

2.11

22.78

2.1

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

231

3.47

22.70

1.3

1.2

0.63

1.90

u/ml

1.04

124

(3045414) Leukocytes [Presence] in Urine

287

1543

1.92

22.65

2.2

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

247

3.36

22.50

1.7

1.3

62670.41

71369.81

e6/l

0.07

171

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3479

31797

1.49

22.48

6.7

5.3

40.25

39.31

mmol/mol

5.98

3266

29499

(3037692) Legionella sp identified in Specimen by Organism specific culture

101

4.90

22.46

1.4

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

179

811

2.26

22.33

1.3

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

124

476

2.65

22.18

5.7

5.3

399.42

369.36

umol/l

0.99

109

411

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3674

33985

1.54

22.18

5.1

4.3

5.99

5.86

mmol/l

6.32

3404

31117

(3011288) Drugs identified in Urine by Screen method

201

958

2.15

22.13

4.6

3.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

4151

39707

2.19

22.09

42.8

17.9

39.15

40.31

12.88

3927

37275

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

234

1183

2.03

22.04

9.8

4.4

1.68

1.65

0.16

220

1088

(3048929) Epstein Barr virus Ab [Presence] in Serum

228

1143

2.05

21.98

1.4

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

107

4.72

21.93

2.8

—

(3007461) Platelets [#/volume] in Blood

4152

39740

2.18

21.73

42.2

17.9

258.91

254.06

e9/l

4.42

4103

38706

(3007930) Methemoglobin/Hemoglobin.total in Blood

233

1183

2.02

21.69

10.1

4.4

0.92

0.89

0.59

219

1092

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1116

2.05

21.60

2.5

2.3

10.03

10.25

g/l

0.27

199

1002

(3042631) Mycobacterium sp identified in Specimen

107

386

2.82

21.58

3.4

2.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

161

708

2.32

21.55

1.4

1.2

—

(3024731) MCV [Entitic volume]

4152

39763

2.16

21.31

42.0

17.8

91.06

90.84

2.31

4128

39189

(3035941) MCH [Entitic mass]

4152

39764

2.16

21.29

42.0

17.8

30.19

30.25

1.32

4128

39188

(3000570) Elastase.pancreatic [Mass/mass] in Stool

194

926

2.15

21.28

1.5

1.4

270.31

290.32

ug/g

0.64

118

505

(3010813) Leukocytes [#/volume] in Blood

4152

39770

2.16

21.18

42.2

17.9

7.06

6.65

e9/l

16.53

4095

38624

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1124

2.04

21.18

2.6

2.3

2.98

2.95

g/l

0.16

199

1016

(3026361) Erythrocytes [#/volume] in Blood

4152

39771

2.16

21.17

42.2

17.8

4.38

4.50

e12/l

39.37

4092

38630

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

153

664

2.35

21.11

1.4

1.2

267.09

268.24

u/ml

0.02

406

(3022313) Gas panel - Capillary blood

261

1394

1.93

21.00

5.5

3.9

—

(3000963) Hemoglobin [Mass/volume] in Blood

4152

39782

2.15

20.97

42.5

17.9

131.10

135.36

g/l

66.27

4129

39204

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

194

934

2.13

20.82

3.4

32.97

65.19

mg/l

1.37

153

765

(3034860) Kappa light chains.free [Mass/volume] in Serum

194

935

2.13

20.76

3.4

3.3

60.08

115.85

mg/l

0.44

154

765

(3034770) Mitochondria Ab [Titer] in Serum

189

906

2.14

20.51

1.3

252.50

974.06

titre

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

249

1322

1.94

20.40

2.7

1.9

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

182

866

2.15

20.14

2.0

1.9

10.48

11.10

mg/l

0.48

171

801

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

186

3.59

20.09

1.7

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

215

3.39

20.07

2.5

2.4

0.20

0.21

e9/l

0.13

188

(1001926) Buprenorphine [Presence] in Urine by Screen method

215

1099

2.01

19.65

3.7

2.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

176

841

2.14

19.27

4.8

3.8

1.58

1.41

mg/l

2.10

166

774

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

186

910

2.09

19.16

3.4

3.3

1.52

2.23

ratio

0.48

(3039000) Anion gap in Blood

146

649

2.29

19.09

13.4

5.9

11.20

11.29

mmol/l

0.12

135

564

(3018572) Chloride [Moles/volume] in Blood

146

650

2.29

19.02

13.4

5.9

105.38

105.31

mmol/l

0.05

135

565

(3010503) CD19 cells [#/volume] in Blood

204

3.37

18.83

2.1

2.5

0.10

0.24

e9/l

1.05

198

(3007566) Smooth muscle Ab [Titer] in Serum

185

912

2.07

18.68

1.3

1.2

192.94

81.90

titre

0.77

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

137

600

2.33

18.55

3.2

2.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

333

2.80

18.49

4.7

3.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

4.61

18.42

1.1

89.78

91.20

0.08

(3016038) Potassium [Moles/volume] in Urine

194

3.39

18.16

2.6

1.2

35.07

36.18

mmol/l

0.12

170

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

266

1498

1.83

18.15

3.2

2.2

4174.01

5781.31

u/l

0.38

588

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

227

1216

1.91

18.11

6.0

4.1

24.73

24.86

mmol/l

0.27

209

1124

(40760888) Immunoglobulin light chains.free panel - Serum

149

685

2.22

17.99

3.7

3.5

—

(4281824) Cell count and differential, peritoneal fluid

344

2.74

17.95

1.2

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

198

1018

1.99

17.81

3.1

2.2

1.11

0.89

g/l

0.31

167

888

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

225

1212

1.90

17.66

2.5

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

188

952

2.02

17.65

1.5

1.4

11.50

10.83

u/l

0.25

160

776

(3020191) Ethanol [Moles/volume] in Serum or Plasma

254

3.03

17.64

2.5

1.5

1.14

1.18

promille

0.08

199

(3016879) Cocaine [Presence] in Urine

237

1299

1.87

17.63

3.7

2.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

137

614

2.27

17.59

1.5

1.4

133.16

117.89

u/ml

0.31

119

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

387

2442

1.64

17.56

2.5

2.4

18.83

23.64

au/ml

0.64

204

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

147

679

2.21

17.55

1.6

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

359

2226

1.67

17.44

1.4

1.3

62.76

50.41

au/ml

0.30

124

(3000764) Benzodiazepines [Presence] in Urine

249

1393

1.84

17.36

3.6

2.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

242

3.05

17.20

1.3

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

307

2.80

17.18

4.1

3.0

57.05

56.16

0.14

264

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

4.49

17.03

1.1

1.2

83.71

89.84

0.37

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

4.49

17.03

1.3

1.2

104.89

103.95

0.05

(3028300) Cannabinoids [Presence] in Urine

250

1410

1.82

16.98

3.6

2.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

140

644

2.21

16.90

4.0

3.2

244.60

737.56

u/ml

0.64

128

598

(3027008) Opiates [Presence] in Urine

249

1405

1.82

16.89

3.6

2.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

164

3.51

16.87

1.1

—

(3016228) CD19 cells/100 cells in Blood

141

3.72

16.79

1.9

2.2

6.67

9.23

0.99

136

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

165

3.49

16.72

1.6

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

125

551

2.31

16.71

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

161

3.51

16.60

1.6

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

309

2.75

16.41

2.0

1.6

57.32

58.84

0.13

183

(3049717) Cytology report of Urine Cyto stain

204

1092

1.91

16.33

3.0

2.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

117

507

2.34

16.27

1.4

1.2

2.84

4.56

u/ml

0.78

170

(3037121) Protein [Mass/volume] in Urine

208

1123

1.90

16.22

3.5

3.0

0.51

0.28

g/l

1.21

107

437

(3016018) Differential panel - Cerebral spinal fluid

351

2.63

16.22

1.7

1.5

—

(40768443) Skin Pathology biopsy report

254

1460

1.79

16.20

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

312

1901

1.69

16.18

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

122

3.88

16.15

2.7

2.1

9.10

11.14

0.55

112

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

146

3.59

15.98

1.8

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

189

994

1.94

15.95

1.3

7.62

37.73

u/ml

—

(3006653) Thiamine [Moles/volume] in Blood

156

3.49

15.90

1.6

1.2

141.91

137.15

nmol/l

0.33

156

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

350

2.60

15.79

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

260

2.88

15.76

1.1

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

107

4.05

15.66

2.0

2.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

114

497

2.33

15.65

1.4

1.3

—

(3023410) Appearance of Cerebral spinal fluid

346

2.61

15.63

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

149

725

2.09

15.62

1.2

1.3

1.53

3.42

u/ml

—

(3008295) Osmolality of Serum or Plasma

341

2.61

15.56

1.7

1.5

282.43

279.04

mosm/kgh2o

0.60

268

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

198

1068

1.89

15.50

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

114

500

2.31

15.44

1.4

1.2

4.92

4.83

u/ml

0.02

215

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

146

3.52

15.24

3.7

3.8

—

(40768793) Breast Pathology biopsy report

161

817

2.01

15.07

1.4

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

173

902

1.96

14.99

2.8

2.2

0.01

0.03

g/l

0.84

158

832

(3019977) pH of Arterial blood

153

3.43

14.91

4.0

2.5

7.42

0.05

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

263

2.81

14.87

1.1

1.2

174.29

202.00

titre

0.11

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

178

940

1.93

14.86

2.7

2.1

37.25

37.89

g/l

0.65

154

831

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

155

3.38

14.62

2.1

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

177

942

1.92

14.45

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

134

647

2.11

14.36

2.5

1.9

0.98

0.84

nmol/l

1.15

114

543

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

128

3.62

14.35

5.5

4.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

171

902

1.93

14.33

1.3

6.84

6.92

u/ml

0.00

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

253

2.80

14.19

1.7

1.5

24.89

33.58

1.26

146

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

284

1749

1.67

14.14

2.5

2.4

—

(36660697) Celiac disease serology panel - Serum

426

2891

1.53

14.08

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

195

3.05

14.03

13.7

10.9

0.63

0.61

mmol/l

0.23

178

(3027944) Amphetamines [Presence] in Urine

236

1385

1.74

14.03

3.4

2.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

266

2.74

14.01

4.1

2.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

121

3.66

13.97

2.2

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

155

3.32

13.92

2.1

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

4.14

13.91

2.7

2.0

125.24

193.47

e6/l

0.82

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

161

842

1.95

13.85

2.8

2.2

0.00

g/l

-0.00

146

776

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

160

835

1.95

13.85

2.8

2.2

0.00

g/l

-0.00

146

775

(21494814) CD8 cells/100 lymphocytes in Specimen

136

3.48

13.85

2.0

2.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

268

2.72

13.82

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

156

3.30

13.79

1.2

1.1

—

(3022621) pH of Urine by Test strip

348

2269

1.58

13.75

3.9

2.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

181

988

1.87

13.69

1.4

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.98

13.59

1.6

2.1

672.67

4404.00

u/ml

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

119

3.64

13.54

2.2

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

119

3.64

13.54

2.2

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

170

917

1.89

13.34

1.3

12.34

7.89

u/ml

0.26

150

(3035637) Corticotropin [Mass/volume] in Plasma

405

2.35

13.31

1.7

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

130

3.49

13.30

28.3

25.1

122.45

116.22

ug/l

0.21

108

(3037756) Immunofixation for Serum or Plasma

125

606

2.09

13.28

1.8

1.6

—

(3000330) Specific gravity of Urine by Test strip

272

1684

1.66

13.28

4.6

3.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

118

560

2.14

13.25

1.4

33.65

27.22

u/l

1.09

103

464

(40768795) Lymph node Pathology biopsy report

310

2.54

13.15

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.52

13.05

1.2

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

100

447

2.27

13.02

1.1

1.54

1.50

g/l

0.55

405

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

182

1013

1.83

12.95

1.9

1.8

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

222

1313

1.73

12.86

2.1

1.6

380.73

296.26

mu/l

2.24

207

1180

(3016650) Hepatitis A virus Ab [Presence] in Serum

116

554

2.12

12.83

1.1

—

(3000012) Reticulocyte production index

389

2.34

12.67

2.3

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

545

3964

1.43

12.63

2.2

2.0

—

(3028433) Virus identified in Specimen by Culture

3.84

12.60

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

174

3.01

12.16

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

353

2.38

12.14

20.5

4.8

7.17

7.27

mmol/l

0.11

298

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

4.00

11.90

1.7

1.6

0.35

0.36

ug/l

0.04

(3045424) Erythrocytes [Presence] in Urine

115

564

2.07

11.89

1.7

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

197

1153

1.74

11.86

1.8

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

314

2.45

11.85

2.0

2.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

376

2.31

11.82

1.5

33.68

33.08

g/l

0.17

346

(3017732) Neutrophils [#/volume] in Blood

348

2358

1.52

11.56

3.8

2.7

5.93

5.16

e9/l

0.33

282

1939

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

394

2.26

11.46

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

115

574

2.03

11.36

1.6

1.5

0.39

0.36

nmol/l

0.06

456

(3042111) Morphology [Interpretation] in Bone marrow Narrative

106

514

2.09

11.31

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

442

2.18

11.27

1.2

1.3

37.56

44.85

u/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

193

2.82

11.25

1.3

1.1

—

(3045142) Bone marrow Pathology biopsy report

341

2.34

11.20

1.4

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3537

33396

1.33

11.20

4.4

3.7

1.38

1.27

mmol/l

13.41

3277

30704

(3036782) Glucose [Moles/volume] in Pleural fluid

274

2.51

11.20

1.4

6.32

6.33

mmol/l

0.01

256

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

106

516

2.08

11.20

1.2

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

216

2.71

11.19

2.7

3.3

25.13

27.76

mu/l

0.18

207

(3010838) Calcium [Moles/time] in 24 hour Urine

119

605

1.99

11.17

1.7

1.8

4.97

5.14

mmol/24h

0.22

104

526

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3725

35453

1.37

11.12

5.3

4.6

2.73

2.81

mmol/l

6.27

3476

32830

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

294

2.44

11.04

1.2

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

229

2.64

11.04

1.9

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

281

1837

1.57

10.98

1.4

1.3

25.40

29.41

iu/l

1.39

239

1576

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

100

483

2.10

10.80

1.1

124.35

117.36

1.04

434

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

139

754

1.87

10.79

1.2

1.3

49.22

43.84

u/ml

0.12

(3000492) Spirometry study

469

3415

1.42

10.75

1.7

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

586

4443

1.37

10.55

2.3

2.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3665

34852

1.34

10.53

4.8

4.2

4.61

4.73

mmol/l

10.02

3442

32457

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.64

10.46

1.5

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

365

2.24

10.42

3.1

2.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

107

3.38

10.25

2.1

2.0

8.04

10.26

mg/l

1.86

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

440

2.11

10.22

1.8

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3640

34614

1.33

10.19

4.7

4.1

1.43

1.49

mmol/l

17.63

3399

32064

(3003338) MCHC [Mass/volume]

3269

30657

1.27

10.14

36.0

15.5

331.19

332.28

g/l

9.41

3249

30436

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

123

3.19

10.12

1.2

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

222

2.59

10.10

1.1

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

240

2.52

10.07

1.0

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

5.02

10.03

1.0

0.83

0.16

u/ml

0.57

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

223

2.58

10.02

1.1

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

124

3.16

9.99

1.5

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

124

3.16

9.99

1.5

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

302

2.34

9.98

4.3

4.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

26.06

9.80

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.58

9.64

5.4

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.58

9.64

5.4

2.8

—

(3014051) Protein [Presence] in Urine by Test strip

157

917

1.74

9.58

3.1

2.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

501

2.00

9.48

1.3

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

166

2.79

9.47

1.6

1.8

2.00

3.61

u/field

0.60

123

(3022493) Free Hemoglobin [Mass/volume] in Plasma

113

3.20

9.43

3.1

7.2

48.65

70.99

mg/l

1.61

(3036670) Protein [Mass/volume] in Synovial fluid

4.12

9.42

1.5

1.2

40.43

38.15

g/l

0.39

(3008037) Lactate [Moles/volume] in Venous blood

121

657

1.87

9.41

4.3

2.8

1.57

mmol/l

0.01

114

636

(3020876) Protein [Mass/time] in 24 hour Urine

330

2.23

9.36

2.7

2.2

1.64

1.28

g/24h

0.51

171

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

263

2.38

9.21

1.2

1.1

229.89

260.56

mg/l

0.87

230

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.55

9.21

1.3

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

386

2.12

9.12

1.7

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

386

2.12

9.12

1.7

1.5

15.40

24.56

iu/ml

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

400

2.10

9.08

1.8

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

101

524

1.95

9.02

1.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

388

2.11

9.01

1.7

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

360

2581

1.43

8.98

1.3

1.2

124.27

153.82

iu/ml

0.86

140

964

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

337

2.19

8.91

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

7.44

8.91

2.8

1.8

49.20

47.78

umol/l

0.05

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

213

2.51

8.86

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

138

796

1.76

8.83

1.7

1.3

—

(3042733) HLA Ab [Presence] in Serum

3.35

8.74

4.9

4.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

386

2.09

8.74

1.7

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

302

2.24

8.68

1.5

1.4

13622.06

70511.93

e6/l

1.46

178

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

216

2.47

8.61

2.0

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

216

2.47

8.61

1.3

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

342

2.15

8.61

1.5

1.4

1646.85

2548.25

e6/l

0.76

248

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.95

8.59

1.4

2.2

16.49

17.22

umol/l

0.08

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.56

8.58

1.6

2.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

211

2.48

8.53

1.6

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

10.03

8.51

2.6

3.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

514

1.93

8.50

1.2

—

(3002619) Bacteria identified in Specimen by Culture

3.80

8.50

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

292

2.24

8.50

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

116

643

1.83

8.49

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

392

2.06

8.41

1.7

1.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

353

2.12

8.35

2.7

2.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

4.65

8.34

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.65

8.34

4.6

5.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

407

2.03

8.33

1.2

1.3

—

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

421

2.02

8.31

1.2

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

394

2.05

8.30

1.7

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

150

2.75

8.27

1.1

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

277

2.26

8.22

1.3

1.2

39.47

40.69

mg/l

0.10

232

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

162

2.67

8.20

1.5

1.2

49.83

73.81

—

(21494434) Karyotype in Bone marrow

271

2.27

8.20

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

259

2.30

8.16

1.7

2.1

1.64

1.82

u/field

0.16

107

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.58

8.11

1.2

1.1

—

(3011985) Renin [Units/volume] in Plasma

440

1.97

8.04

1.5

118.33

68.38

mu/l

0.64

390

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

3.85

7.96

1.0

1.2

2.89

3.34

u/ml

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

125

723

1.75

7.96

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

360

2.07

7.95

1.1

95.09

97.27

0.27

342

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

506

1.90

7.90

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

257

2.27

7.86

1.1

1.2

—

(3035880) pH of Pleural fluid

155

2.66

7.79

1.3

1.4

—

(3019225) pH of Specimen

433

3283

1.35

7.74

6.2

4.0

—

(3011648) Oxygen content in Venous blood

229

2.33

7.62

2.5

2.8

10.52

11.28

0.57

229

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.72

7.62

5.4

6.8

—

(3012441) Differential panel - Pleural fluid

293

2.17

7.61

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.69

7.57

1.2

1.1

—

(3024263) Appearance of Synovial fluid

158

2.61

7.51

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

286

2033

1.44

7.50

2.0

1.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

153

2.63

7.44

1.2

1.1

1530.75

1465.99

miu/ml

0.14

153

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.13

7.40

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

290

2077

1.42

7.30

2.4

2.2

11.03

12.27

nmol/l

1.60

256

1859

(3004616) Nuclear Ab [Presence] in Serum

421

1.94

7.28

1.3

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

4.14

7.26

1.6

1.1

49.64

52.42

0.08

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

237

3365

0.69

7.23

1.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

3.31

7.23

1.5

1.1

16.63

16.82

umol/l

0.09

(3038515) Glucose [Moles/volume] in Venous blood

109

624

1.77

7.23

4.6

2.9

7.62

7.47

mmol/l

0.16

103

607

(40765096) Chromosome analysis panel by Banding

100

3.01

7.18

1.4

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

261

2.20

7.18

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.30

7.17

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.94

7.15

1.6

1.5

—

(3045788) Cell count panel - Pleural fluid

268

2.18

7.14

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

211

2.34

7.12

1.7

1.5

36.88

18.28

u/ml

—

(40768806) Pleura Pathology biopsy report

302

2.10

7.08

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1065

9141

1.22

6.96

1.8

1.6

1.51

1.36

mmol/l

2.73

925

7717

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

160

2.51

6.83

1.8

1.6

3.43

8.28

nmol/l

0.80

130

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

120

2.76

6.79

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

288

2.10

6.74

1.5

1.2

1.33

1.44

nmol/l

0.32

266

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

344

2573

1.37

6.72

2.2

1.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

276

2.12

6.66

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

276

2.12

6.66

1.2

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

372

1.95

6.62

1.2

1.1

—

4.64

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

277

2.11

6.60

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

277

2.11

6.60

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.18

6.56

1.1

1.2

—

(40768441) Liver Pathology biopsy report

245

2.18

6.55

1.9

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

278

2.10

6.55

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

129

2.65

6.47

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

320

2.02

6.46

1.2

1.1

52.37

75.11

u/l

1.49

285

(1761482) Bacteria [#/volume] in Urine by Culture

128

791

1.64

6.45

5.9

4.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

565

1.75

6.39

3.3

3.1

0.82

0.80

nmol/l

0.20

437

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.58

6.30

6.0

6.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.10

6.30

1.6

1.5

148.27

144.56

nmol/l

0.03

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.90

6.30

2.2

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

276

2.08

6.28

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

186

2.33

6.23

1.1

—

(3044927) Protein electrophoresis panel - Urine

304

2.02

6.23

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

6.27

6.15

2.3

2.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

104

2.80

6.14

1.4

1.5

61.42

65.36

0.22

(3042517) Benzodiazepines panel - Urine

5.73

6.13

1.3

2.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.76

6.08

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

105

2.77

6.04

1.9

1.2

28.50

16.88

—

(3004451) EKG impression Narrative

140

2.51

6.01

1.5

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

357

1.92

6.00

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

155

1021

1.54

5.99

1.1

0.63

4.80

u/ml

—

130

(3034274) Bile acid [Moles/volume] in Serum --fasting

473

1.79

5.96

1.8

2.1

5.31

6.53

umol/l

0.35

336

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

262

2.07

5.94

1.2

33.75

47.80

u/ml

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

178

1212

1.49

5.89

1.4

1.3

210.01

229.37

miu/ml

0.27

593

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

140

909

1.56

5.79

1.9

4.87

iu/l

0.00

340

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

149

2.43

5.77

1.6

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

149

2.43

5.77

1.6

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

378

1.87

5.69

2.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.77

5.62

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

248

2.07

5.60

3.5

2.2

—

(3052592) Norovirus Ag [Presence] in Stool

3.40

5.58

1.9

1.4

—

(3012565) Volume of 24 hour Urine

164

2.33

5.57

2.1

2080.25

1865.49

0.47

144

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.82

5.53

1.3

1.2

1.40

1.71

mmol/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

230

2.10

5.48

1.3

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.19

5.38

2.3

1.9

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

199

2.17

5.37

1.0

1.1

3.61

6.92

nmol/l

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

199

2.17

5.37

1.1

1.2

1.09

1.05

ratio

1.11

(3013139) Helicobacter pylori Ag [Presence] in Stool

315

2410

1.33

5.34

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

3.10

5.33

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.40

5.21

11.5

7.2

5.50

5.74

mmol/l

0.09

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

182

2.21

5.21

2.5

2.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.85

5.11

1.1

—

(3014271) Vancomycin [Susceptibility]

140

2.37

5.05

3.1

3.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.18

5.03

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

545

1.67

5.00

1.1

22.39

1068.76

iu/ml

0.54

127

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.97

4.98

1.4

1.3

30.69

34.40

0.19

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

980

8593

1.18

4.86

5.0

4.8

7.40

2.82

ug/l

0.56

877

7716

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

149

2.29

4.86

2.0

2.2

51.96

49.87

umol/l

0.10

127

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

208

2.08

4.83

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

116

755

1.55

4.81

2.6

2.3

223.56

94.94

ug/min

0.83

457

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

483

1.69

4.78

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.75

4.77

1.2

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

217

2.04

4.71

1.2

1.1

11.38

11.47

iu/ml

0.01

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

108

2.51

4.70

2.2

2.8

83.74

155.68

au/ml

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

7.15

4.65

1.1

1.0

—

(3017704) Immunofixation for Urine

165

2.19

4.64

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

127

2.37

4.64

1.1

57.60

440.69

ng/l

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.01

4.62

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

185

2.12

4.62

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

184

1325

1.41

4.60

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

443

1.71

4.60

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

153

2.23

4.58

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

199

2.07

4.58

1.7

1.5

6.31

5.62

u/l

0.15

170

(3047189) Immunofixation for 24 hour Urine

147

2.25

4.56

2.1

1.7

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

8.20

4.56

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

110

2.46

4.54

1.1

—

(21494755) Public health laboratory ask at order entry panel

282

3613

0.77

4.51

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

163

2268

0.71

4.51

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

112

735

1.54

4.50

5.6

3.3

22.37

24.68

mg/l

0.41

441

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

194

2.07

4.49

1.2

1.1

0.95

1.13

u/l

2.40

(3024471) HLA-A [Type]

2.53

4.45

1.0

—

(3024932) HLA-DR beta [Type]

2.53

4.45

1.2

1.1

—

(3008898) HLA-B27 [Presence]

179

1291

1.40

4.45

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

188

2.08

4.45

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

250

1.93

4.43

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

118

2.38

4.39

3.6

2.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

217

1.99

4.35

1.4

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

119

2.36

4.31

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

332

1.79

4.30

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

101

2.48

4.29

2.2

2.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

102

664

1.55

4.27

1.1

2.64

5.36

u/ml

2.21

337

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

408

1.70

4.24

1.4

341.17

335.28

pmol/l

0.04

357

(3048879) Bone marrow aspiration report

2.63

4.22

2.7

1.6

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.42

4.18

1.1

1.0

0.05

u/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

111

740

1.51

4.17

1.2

1.1

1.54

2.44

u/ml

0.71

363

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

5.89

4.12

2.2

1.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.51

4.04

1.2

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.34

4.04

2.6

2.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

149

2.16

4.01

1.9

21.06

174.63

ug/l

0.49

136

(40757373) Influenza virus identified in Isolate

2.82

3.95

2.1

1.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.45

3.93

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.45

3.93

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

144

2.16

3.92

1.4

1.3

156.61

153.33

mmol/24h

0.08

144

(3020911) Cortisol [Moles/time] in 24 hour Urine

112

2.33

3.91

1.7

1.4

86.85

138.08

nmol/24h

0.41

112

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

112

2.33

3.91

2.7

2.5

31.17

28.77

umol/l

0.25

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

2.57

3.88

3.6

2.8

132.00

162.01

ng/l

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.45

3.87

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

199

1.97

3.86

1.3

1.7

7.40

6.36

u/l

0.17

173

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

278

1.81

3.83

1.1

1.0

313.81

294.37

mg/l

1.02

249

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

5.27

3.82

2.6

2.4

2.65

3.08

mg/l

—

(3026480) Teichoate Ab [Titer] in Serum

6.01

3.81

1.1

—

(40768446) Kidney Pathology biopsy report

114

2.29

3.77

2.0

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.19

3.77

1.6

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.59

3.74

2.0

3.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.45

3.71

1.2

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.68

3.67

2.3

2.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.86

3.62

2.4

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

253

1988

1.29

3.62

1.1

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

110

2.28

3.61

1.1

0.10

2.48

u/ml

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.35

3.57

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

509

1.56

3.52

1.2

49.26

35.38

u/l

0.50

441

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

738

6483

1.17

3.50

1.5

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

6.16

3.50

1.1

1.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.62

3.49

1.5

1.6

22.75

6.95

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

152

2.05

3.45

1.0

104.76

92.55

1.20

113

(3008401) Mugwort IgE Ab [Units/volume] in Serum

643

1.49

3.39

1.1

1.31

0.88

u/ml

0.29

270

(3017509) Phencyclidine [Presence] in Urine

3.76

3.38

1.3

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.76

3.38

1.2

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

120

2.17

3.37

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.84

3.35

1.3

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

121

2.16

3.31

2.5

3.2

7.09

7.77

mg/l

0.27

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

376

1.63

3.29

2.2

2.1

24.25

22.14

mg/l

0.13

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.30

3.26

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.03

3.24

7.2

7.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.03

3.24

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

496

1.54

3.23

1.9

1.4

5.35

3.77

ug/l

0.35

442

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

129

2.10

3.23

1.9

2.4

250.35

155.59

nmol/l

0.78

112

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

378

1.62

3.23

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.67

3.22

2.5

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

206

1.85

3.20

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

171

1297

1.33

3.20

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

150

2.01

3.19

1.9

1.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.17

3.19

1.1

1.3

—

(3034426) Prothrombin time (PT)

110

2.19

3.18

1.5

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

556

1.50

3.14

1.2

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.47

3.12

1.0

1.1

0.33

1.31

u/ml

0.70

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.54

3.12

1.1

0.67

0.71

umol/24h

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

4.51

3.11

6.4

2.6

1.77

1.85

mg/l

—

(3044007) Cell count panel - Peritoneal fluid

2.29

3.09

2.6

1.6

—

(3020491) Glucose [Moles/volume] in Blood

253

1.75

3.08

2.1

1.9

8.18

6.71

mmol/l

1.19

171

(3017569) Oxygen content in Arterial blood

133

2.04

3.00

1.8

1.9

—

(3013336) Amino acids [Identifier] in Serum or Plasma

10.01

2.98

2.2

3.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

10.01

2.98

8.4

3.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

557

1.48

2.93

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.32

2.91

1.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

108

2.14

2.90

2.4

1.9

552.18

673.44

e6/l

0.23

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.70

2.88

1.1

1.2

1.90

1.71

mmol/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

115

2.09

2.88

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

5.39

2.87

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

136

1.99

2.84

2.6

2.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

602

1.45

2.84

1.1

1.37

1.85

u/ml

0.33

290

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.34

2.81

2.2

3.1

1.09

0.58

u/field

0.52

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.65

2.79

1.8

1.4

0.15

0.21

nmol/l

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

110

2.10

2.78

1.4

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

427

3658

1.19

2.77

1.7

—

(3033799) Differential panel - Peritoneal fluid

2.24

2.70

1.5

1.7

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.01

2.70

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

6.01

2.70

1.2

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

6.01

2.70

1.2

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.01

2.69

1.0

1.1

—

(3001729) Color of Synovial fluid

3.76

2.67

1.8

1.6

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

3.06

2.56

1.1

0.00

0.77

u/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

765

6887

1.13

2.55

4.3

4.1

21.17

21.76

0.44

342

3319

(3000285) Sodium [Moles/volume] in Blood

2.73

2.54

1.3

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

5.46

2.54

1.3

1.0

194.00

272.57

nmol/l

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

5.46

2.54

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

5.46

2.54

2.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.23

2.53

1.1

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

434

3754

1.17

2.53

1.5

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

2.98

2.48

1.5

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

137

1.90

2.45

9.1

12.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.67

2.45

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.01

2.40

2.8

2.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.01

2.40

2.2

7.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

6.26

2.37

1.0

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

426

1.49

2.36

1.3

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.42

2.36

3.0

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

104

2.02

2.35

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.61

2.35

2.3

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

306

1.58

2.35

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.89

2.25

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.28

2.24

1.3

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.56

2.21

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.20

1.1

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

483

1.44

2.20

1.2

1.1

1.86

4.02

u/ml

1.35

183

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

233

1.64

2.19

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.34

2.18

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.24

2.17

2.7

2.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.69

2.15

1.0

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.30

2.14

4.0

1.8

1.20

1.21

mmol/l

0.07

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.20

2.09

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

658

1.36

2.08

1.6

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.91

2.07

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

124

1.86

2.06

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

124

1.86

2.06

1.5

14.56

14.45

pmol/l

0.03

107

(3009871) Measles virus Ab [Titer] in Serum

117

1.88

2.05

1.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.55

1.94

2.8

2.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.55

1.94

1.8

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.57

1.94

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

2.97

1.93

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

159

1294

1.24

1.84

1.8

1.9

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

229

1.58

1.84

1.0

0.13

1.05

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.21

1.84

1.2

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.53

1.83

1.0

1.7

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

4.17

1.82

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

2.76

1.79

1.1

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

231

1.56

1.78

2.0

1.5

84.78

81.45

umol/l

0.18

231

(3029075) Extractable nuclear Ab panel - Serum

1.90

1.75

1.1

1.0

—

(3007463) Buprenorphine [Presence] in Urine

3.34

1.74

1.7

5.0

—

(40758292) HTLV I+II Ab panel - Serum

2.23

1.73

1.1

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.23

1.73

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.23

1.73

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.23

1.73

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.92

1.72

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

525

1.36

1.71

1.2

1.0

3.13

3.88

u/ml

0.33

240

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.85

1.71

1.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.85

1.71

1.2

1.1

2.20

1.00

u/field

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.29

1.70

1.3

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

227

1.55

1.67

1.1

0.67

3.03

u/ml

1.03

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

104

1.83

1.67

1.7

1.5

11.97

8.46

ug/l

1.38

104

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.16

1.66

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.16

1.66

1.0

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

3.16

1.66

1.7

1.4

1.97

2.56

nmol/l

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

573

1.33

1.63

1.9

181.00

194.09

pmol/l

0.41

537

(3024869) Neuronal Ab [Presence] in Serum

2.25

1.63

1.3

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.25

1.63

1.3

1.0

—

(3016750) Collection duration of Urine

181

1.61

1.63

2.2

554.21

488.40

min

2.99

134

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.57

1.61

1.0

1.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.07

1.59

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.33

1.58

1.1

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.00

1.58

1.3

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.69

1.58

4.4

7.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.20

1.56

4.1

3.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.20

1.56

1.4

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.34

1.52

1.8

1.3

249.40

315.13

umol/24h

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

850

0.75

1.51

1.3

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.83

1.51

2.4

1.8

838.11

24291.88

e6/l

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.16

1.50

1.3

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.90

1.49

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.23

1.46

1.1

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.23

1.46

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.50

1.45

1.0

1.1

—

4.50

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.13

1.44

1.0

—

(3022475) Manganese [Moles/volume] in Blood

2.73

1.43

1.2

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.97

1.43

1.2

1.4

19.71

20.05

—

(3001019) Free T4 and TSH panel - Serum or Plasma

180

2111

0.85

1.41

1.6

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.25

1.40

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.42

1.39

1.1

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

165

1394

1.19

1.38

1.7

1.6

4.37

3.95

mg/l

0.19

131

1005

(3005033) Fetal Nuchal fold Thickness US

826

0.76

1.38

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1004

0.78

1.37

1.3

1.4

—

(3020650) Glucose [Presence] in Urine

1.80

1.37

1.8

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

104

1.73

1.36

1.1

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1003

0.78

1.36

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1003

0.78

1.36

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

999

0.79

1.32

1.3

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

829

0.77

1.30

1.3

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

209

1.49

1.30

1.0

0.03

0.42

u/ml

—

(3039443) Prostate specific Ag panel - Serum or Plasma

520

0.71

1.29

1.7

1.6

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

2.78

1.28

1.0

1.5

3.60

2.06

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.86

1.23

1.4

1.2

439.29

248.02

pmol/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

279

1.40

1.22

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1083

0.81

1.19

1.4

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.31

1.18

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.11

1.18

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.05

1.15

1.8

1.3

—

(1761868) Lipid panel - Serum or Plasma

1233

12895

0.94

1.12

3.0

2.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.78

1.10

1.2

1.3

177.84

449.27

ug/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.26

1.10

4.7

1.9

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.38

1.09

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.82

1.09

1.0

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

243

0.62

1.08

1.1

1.3

1.50

1.59

g/l

0.92

243

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.76

1.06

2.6

2.1

22.78

2.20

ug/l

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

121

1.57

1.05

1.2

1.1

8.27

14.17

u/ml

0.56

(3004775) Volume in Urine collected for unspecified duration

245

1.39

1.05

2.4

2.3

757.91

591.84

1.33

160

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.71

1.05

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.71

1.05

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.71

1.05

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.71

1.05

1.3

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

443

4084

1.09

1.03

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

2.06

1.02

1.0

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.92

1.02

2.4

3.0

—

(3006270) Folate [Moles/volume] in Blood

291

1.34

0.99

1.1

370.45

380.79

nmol/l

0.11

258

(4034850) Laboratory test

135

1162

1.17

0.98

13.1

9.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.89

0.94

1.1

1.55

1.67

umol/24h

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.22

0.93

1.2

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.22

0.93

6.2

4.9

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.63

0.90

1.2

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

107

912

1.18

0.90

1.1

—

(4212803) Bone marrow aspirate examination

2.07

0.89

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.86

0.87

1.4

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.67

0.85

1.3

—

(3006462) Nitrate [Presence] in Urine

162

1.42

0.84

3.2

2.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

529

4966

1.07

0.83

3.0

0.74

0.75

ug/l

0.10

370

3265

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.67

0.78

1.9

1.7

44.34

44.77

pmol/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

186

0.64

0.76

1.0

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

350

1.26

0.75

3.8

4.7

128.36

68.99

u/ml

0.33

105

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

440

1.23

0.75

1.2

1.0

0.96

0.30

u/ml

0.41

120

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

166

1.39

0.75

1.1

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.58

0.71

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.56

0.68

1.3

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

492

1.20

0.68

1.4

1.3

6.95

7.24

mmol/l

0.48

441

(3038177) Helicobacter pylori Ab [Presence] in Serum

596

1.18

0.65

1.4

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

304

1.25

0.65

3.3

3.0

84.86

26.72

mg/l

0.56

224

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

247

0.73

0.64

1.3

1.5

—

(3025130) Human papilloma virus identified in Specimen

534

1.18

0.62

2.0

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

104

1.44

0.62

5.1

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

138

1.38

0.62

1.1

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.60

0.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

166

1.33

0.58

2.9

2.0

66.33

110.45

ug/min

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.62

0.55

1.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

786

1.14

0.54

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

552

1.16

0.54

1.1

1.0

1.43

3.20

u/ml

2.14

263

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

545

1.16

0.52

1.5

1.6

—

(40768800) Prostate Pathology biopsy report

508

1.16

0.51

1.3

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.50

0.51

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.50

0.51

16.3

7.5

—

(1002224) Polysomnography panel

156

1432

1.09

0.49

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

201

1.25

0.44

1.2

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

112

1228

0.91

0.43

1.5

1.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.61

0.43

2.2

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

203

1.23

0.42

1.4

1.3

5.43

5.77

mmol/l

0.88

194

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.7

—

204.07

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.47

0.40

1.6

1.3

—

640.53

—

(3014891) Appearance of Pleural fluid

1.43

0.39

1.4

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

1.39

0.38

1.2

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.39

0.38

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

173

1848

0.93

0.38

1.4

1.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.35

0.37

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

145

0.76

0.34

1.7

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

209

0.81

0.32

1.5

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

674

1.10

0.32

1.3

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

149

1402

1.07

0.30

1.6

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.25

0.29

1.1

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.23

0.29

1.0

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

242

1.16

0.28

1.1

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

224

1.16

0.27

1.2

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.70

0.26

12.2

7.4

85.80

74.56

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.32

0.23

2.6

2.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.25

0.22

1.0

2.0

—

(4146454) Self-monitoring of blood glucose

337

0.89

0.22

2.6

2.7

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

166

0.84

0.20

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

1.18

0.19

2.3

6.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.17

0.17

1.9

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.17

0.17

3.7

6.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

407

4158

0.98

0.16

4.6

4.3

31.58

32.60

1.10

309

2831

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

226

1.11

0.15

1.0

304.50

326.24

ng/l

0.14

144

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

228

1.10

0.13

1.0

863.15

689.35

ng/l

0.96

143

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

230

1.09

0.11

1.0

32.21

44.47

ng/l

1.29

144

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

209

0.91

0.11

1.4

125.41

211.46

pmol/l

1.01

209

(3015183) Erythrocyte sedimentation rate

185

1.08

0.08

1.1

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

286

0.94

0.07

2.2

1.4

0.95

g/l

0.01

286

(3029396) Erythrocyte agglutination [Presence] in Blood

1.06

0.07

2.2

3.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

872

1.02

0.05

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

430

1.02

0.02

1.3

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

103

1.07

0.02

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

223

1.03

0.01

6.3

6.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

146

1.03

0.00

1.7

1.6

—

(3022689) Creatine [Moles/volume] in Urine

1.03

0.00

1.7

1.5

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.8

—

0.24

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

38.60

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.2

—

36.93

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

3.3

—

4.36

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.1

—

69.09

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.98

-0.00

1.0

80.68

76.06

ug/l

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

2.27

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

470

1.00

-0.00

4.4

2.5

13.46

13.12

1.34

465

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_OTHER_COMPLICATIO_SURGI_MEDICAL_CARE_NOT_ELSEW_CLASSIFIED – Other complications of surgical and medical care, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other complications of surgical and medical care, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other complications of surgical and medical care, not elsewhere classified (ST19_OTHER_COMPLICATIO_SURGI_MEDICAL_CARE_NOT_ELSEW_CLASSIFIED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints